Matthias Augustin
#117,546
Most Influential Person Now
Researcher
Matthias Augustin's AcademicInfluence.com Rankings
Matthias Augustincomputer-science Degrees
Computer Science
#4637
World Rank
#4890
Historical Rank
Machine Learning
#971
World Rank
#985
Historical Rank
Artificial Intelligence
#1192
World Rank
#1213
Historical Rank
Database
#1843
World Rank
#1932
Historical Rank
Download Badge
Computer Science
Why Is Matthias Augustin Influential?
(Suggest an Edit or Addition)Matthias Augustin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. (2012) (386)
- Visual analogue scale: evaluation of the instrument for the assessment of pruritus. (2012) (367)
- Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque‐type psoriasis (2009) (352)
- Epidemiology and comorbidity of psoriasis in children (2010) (338)
- Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials (2018) (320)
- Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. (2010) (300)
- National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study (2020) (298)
- Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany (2008) (260)
- S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update (2012) (259)
- Psoriasis: is the impairment to a patient’s life cumulative? (2010) (204)
- Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) (2016) (202)
- Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey (2009) (195)
- Measuring change in quality of life: bias in prospective and retrospective evaluation. (2015) (183)
- Nail psoriasis in Germany: epidemiology and burden of disease (2010) (173)
- Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers (2011) (173)
- The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. (2010) (169)
- Prevalence of Chronic Pruritus in Germany: Results of a Cross-Sectional Study in a Sample Working Population of 11,730 (2010) (164)
- Epidemiology of chronic wounds in Germany: Analysis of statutory health insurance data (2016) (163)
- Adherence in the Treatment of Psoriasis: A Systematic Review (2011) (162)
- Cost‐of‐illness of chronic leg ulcers in Germany (2010) (160)
- Prevalence of Skin Diseases in a Cohort of 48,665 Employees in Germany (2008) (146)
- The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases (2009) (141)
- Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. (2013) (140)
- S3‐Leitlinie zur Therapie der Psoriasis vulgaris (2006) (137)
- Telemedicine in dermatology: findings and experiences worldwide – a systematic literature review (2018) (133)
- European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo (2018) (131)
- Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis. (2020) (125)
- Cost‐of‐illness of leg ulcers in the community (2014) (121)
- Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema (2015) (119)
- Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis (2014) (119)
- Prednisolone vs. ciclosporin for severe adult eczema. An investigator‐initiated double‐blind placebo‐controlled multicentre trial (2010) (118)
- Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest (2015) (117)
- The “Wound‐QoL”: A short questionnaire measuring quality of life in patients with chronic wounds based on three established disease‐specific instruments (2014) (114)
- S3 Guideline for the treatment of psoriasis vulgaris, update – Short version part 1 – Systemic treatment (2018) (111)
- Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study (2006) (110)
- German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version) (2007) (109)
- Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. (2010) (107)
- The global state of psoriasis disease epidemiology: a workshop report (2017) (104)
- Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double‐blind, etanercept‐ and placebo‐controlled study (CIMPACT) (2018) (103)
- German S3-guidelines on the treatment of psoriasis vulgaris (short version) (2012) (100)
- Prevalence and risk factors of actinic keratoses in Germany – analysis of multisource data (2014) (99)
- Cost‐of‐illness in patients with moderate and severe chronic psoriasis vulgaris in Germany (2005) (99)
- Costs and quality of life in patients with moderate to severe plaque‐type psoriasis in Germany: A multi‐center study (2007) (98)
- Evidence‐based (S3) guidelines for the treatment of psoriasis vulgaris (2007) (94)
- Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. (2005) (93)
- Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. (2007) (92)
- Development and validation of a disease-specific questionnaire on the quality of life of patients with chronic venous insufficiency. (1997) (91)
- Willingness to pay and quality of life in patients with atopic dermatitis (2014) (91)
- S3 – Guidelines on the treatment of psoriasis vulgaris Update 2011 (2011) (90)
- Modern wound care – practical aspects of non‐interventional topical treatment of patients with chronic wounds (2014) (88)
- Patient-relevant treatment goals in psoriasis (2016) (87)
- PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents. (2012) (84)
- Satisfaction of Patients After Treatment With Botulinum Toxin for Dynamic Facial Lines (2003) (82)
- CONSENSUS REPORT: Recognizing non‐melanoma skin cancer, including actinic keratosis, as an occupational disease – A Call to Action (2016) (80)
- Effectiveness of Advanced versus Conventional Wound Dressings on Healing of Chronic Wounds: Systematic Review and Meta-Analysis (2013) (80)
- Lebensqualität bei Haut- erkrankungen: Vergleich verschiedener Lebensqualitäts-Fragebögen bei Psoriasis und atopischer Dermatitis (1999) (80)
- German psoriasis registry PsoBest: objectives, methodology and baseline data (2014) (79)
- Prevalence and comorbidities in adults with psoriasis compared to atopic eczema (2017) (77)
- Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness. (1999) (75)
- Die Erfassung von Lebensqualität in der Versorgungsforschung - konzeptuelle, methodische und strukturelle Voraussetzungen. (2009) (75)
- S2k guideline on diagnosis and treatment of atopic dermatitis – short version (2016) (73)
- German Adaptation of the Skindex-29 Questionnaire on Quality of Life in Dermatology: Validation and Clinical Results (2004) (73)
- Quality of psoriasis care in Germany – results of the national study PsoHealth 2007 (2008) (72)
- Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit (2016) (71)
- Validation and Clinical Results of the FLQA-d, a Quality of Life Questionnaire for Patients with Chronic Skin Disease (2000) (70)
- Itch Assessment with Visual Analogue Scale and Numerical Rating Scale: Determination of Minimal Clinically Important Difference in Chronic Itch. (2016) (69)
- Measurement of health‐related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life (2013) (69)
- Prevalence and Disease Burden of Hyperhidrosis in the Adult Population (2013) (68)
- Quality of life evaluation in wounds: validation of the Freiburg Life Quality Assessment‐wound module, a disease‐specific instrument * (2010) (68)
- Prevalence, predictors and comorbidity of dry skin in the general population (2018) (68)
- S3‐Leitlinie zur Therapie der Psoriasis vulgaris Update 2011 (2011) (68)
- Therapy of psoriasis in childhood and adolescence ‐ a German expert consensus (2011) (68)
- Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial (2019) (68)
- Measuring patient‐relevant benefits in pruritus treatment: development and validation of a specific outcomes tool (2009) (67)
- Quality of life and satisfaction of patients with leg ulcers--results of a community-based study. (2011) (67)
- Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. (2013) (65)
- S2k guideline on diagnosis and treatment of atopic dermatitis — short version (2016) (64)
- Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis (2015) (63)
- Psychosomatic Aspects of Chronic Wounds (2003) (62)
- Development, validation and clinical use of the FLQA-I, a disease-specific quality of life questionnaire for patients with lymphedema. (2005) (61)
- A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey (2018) (59)
- Gender and age significantly determine patient needs and treatment goals in psoriasis – a lesson for practice (2019) (59)
- Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis. (2016) (57)
- Rationale and Design of the Hamburg City Health Study (2019) (55)
- Promoting patient‐centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience (2015) (55)
- Quality of life in psoriasis patients (2014) (55)
- S2k Guidelines for the diagnosis and treatment of chronic pruritus – update – short version (2017) (54)
- Willingness to pay and quality of life in patients with rosacea (2013) (54)
- Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis. (2018) (53)
- Psychological Burden in Adult Neurofibromatosis Type 1 Patients: Impact of Disease Visibility on Body Image (2012) (53)
- The global challenge for skin health (2015) (53)
- Compression therapy: scientific background and practical applications (2014) (52)
- Tailoring the Cut-off Values of the Visual Analogue Scale and Numeric Rating Scale in Itch Assessment. (2017) (51)
- Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis (2012) (51)
- Dimensions of patient needs in dermatology: subscales of the patient benefit index (2010) (50)
- Anti‐inflammatory potential of a lipolotion containing coriander oil in the ultraviolet erythema test (2008) (50)
- Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes (2014) (50)
- Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis (2017) (50)
- [Memorandum registry for health services research]. (2010) (50)
- Epidemiologie der Psoriasis in Deutschland ― Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung (2011) (50)
- Cost‐of‐illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany (2011) (50)
- Quality of Care in Chronic Leg Ulcer in the Community: Introduction of Quality Indicators and a Scoring System (2011) (50)
- Time Needed for Treatment Is the Major Predictor of Quality of Life in Psoriasis (2010) (49)
- Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic Review (2015) (49)
- Nail psoriasis as a severity indicator: results from the PsoReal study (2010) (48)
- Neurodermitis S2‐Leitlinie (2009) (48)
- The German National Program on Psoriasis Health Care 2005–2015: results and experiences (2016) (48)
- Treatment of therapy-refractive ulcera cruris of various origins with autologous keratinocytes in fibrin sealant. (2005) (48)
- S2k‐Leitlinie zur Diagnostik und Therapie des chronischen Pruritus – Update – Kurzversion (2017) (47)
- Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. (2004) (47)
- Evaluation of Quality of Care and Guideline-Compliant Treatment in Psoriasis (2009) (46)
- Efficacy, Tolerability and Patient Benefit of Ultrasound-Assisted Wound Treatment versus Surgical Debridement: A Randomized Clinical Study (2011) (46)
- Global Allergy Forum and 3rd Davos Declaration 2015 (2016) (46)
- Secukinumab is superior to fumaric acid esters in treating patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial (2017) (45)
- Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies (2012) (45)
- Evaluation of the Antipruritic Effects of Topical Pimecrolimus in Non-Atopic Prurigo Nodularis: Results of a Randomized, Hydrocortisone-Controlled, Double-Blind Phase II Trial (2013) (44)
- Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany (2012) (44)
- A framework for improving the quality of care for people with psoriasis (2012) (44)
- Thyrotropin-Releasing Hormone (TRH) Promotes Wound Re-Epithelialisation in Frog and Human Skin (2013) (44)
- Skin cancer screening in Germany – perception by the public (2012) (44)
- Diagnosis and treatment of xerosis cutis – a position paper (2019) (43)
- Use of the WoundQoL instrument in routine practice: Feasibility, validity and development of an implementation tool (2014) (43)
- Vacuum Assisted Closure: Recommendations for Use (2008) (43)
- Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2 (2011) (43)
- S3 Guideline for the treatment of psoriasis vulgaris, update – Short version part 2 – Special patient populations and treatment situations (2018) (43)
- Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient‐Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa (2019) (42)
- Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial (2018) (42)
- Benefit Evaluation in Vitiligo Treatment: Development and Validation of a Patient-Defined Outcome Questionnaire (2008) (42)
- Nail psoriasis – a treatment challenge (2013) (42)
- Psychosocial Stress of Patients with Port Wine Stains and Expectations of Dye Laser Treatment (1998) (41)
- Quality‐of‐care for leg ulcers in the metropolitan area of Hamburg – a community‐based study (2012) (41)
- Topical long‐term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice (2014) (41)
- Cost-of-illness analysis of patients with chronic hand eczema in routine care in Germany: focus on the impact of occupational disease. (2013) (41)
- Benefit evaluation in the therapy of chronic wounds from the patients' perspective—development and validation of a new method (2012) (41)
- Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation. (1993) (40)
- [Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis]. (1999) (40)
- Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis (2016) (40)
- Processes of psoriasis health care in Germany – long‐term analysis of data from the statutory health insurances (2012) (40)
- Epidemiology of hidradenitis suppurativa in Germany – an observational cohort study based on a multisource approach (2020) (40)
- Biologics and immunoglobulins in the treatment of pyoderma gangrenosum – analysis of 52 patients (2019) (39)
- Epidemiology and use of compression treatment in venous leg ulcers: nationwide claims data analysis in Germany (2017) (39)
- Epidemiology of skin cancer in the German population: impact of socioeconomic and geographic factors (2018) (39)
- Barriers to guideline‐compliant psoriasis care: analyses and concepts (2016) (39)
- Economic considerations in psoriasis management. (2008) (39)
- Prevalence of Obesity in Patients with Psoriasis: Results of the National Study PsoHealth3 (2015) (39)
- S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2 (2019) (39)
- Methods of Outcomes Measurement in Nail Psoriasis (2010) (38)
- [Epidemiology of psoriasis in Germany--analysis of secondary health insurance data]. (2011) (37)
- Quality of psoriasis care in Germany: results of the national health care study “PsoHealth3” (2016) (36)
- Topology of psoriasis in routine care: results from high‐resolution analysis of 2009 patients (2019) (36)
- Systemic treatment with corticosteroids in psoriasis–health care provision far beyond the S3‐guidelines (2011) (35)
- Validity and feasibility of the wound‐QoL questionnaire on health‐related quality of life in chronic wounds (2017) (35)
- Compression therapy – cross‐sectional observational survey about knowledge and practical treatment of specialised and non‐specialised nurses and therapists (2017) (34)
- Empfehlungen zur Erfassung von Lebensqualität in der Dermatologie (2000) (34)
- Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany (2015) (34)
- Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany (2019) (34)
- Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double‐blind, controlled, pilot study in dry skin (2017) (34)
- Psoriasis registries worldwide: systematic overview on registry publications (2016) (34)
- Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study (2019) (33)
- Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non‐Melanoma Skin Cancer (2019) (33)
- Evaluation of patient-relevant outcomes of lymphedema and lipedema treatment: development and validation of a new benefit tool. (2014) (33)
- Loss of Interface Pressure in Various Compression Bandage Systems over Seven Days (2014) (32)
- Rapid improvements in health‐related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER‐2 and UNCOVER‐3 (2017) (32)
- Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes. (2015) (32)
- Praxis der Teledermatologie (2018) (32)
- [S3-Guidelines for the therapy of psoriasis vulgaris]. (2006) (32)
- Patient-Reported Outcome Measures in Pruritus: A Systematic Review of Measurement Properties. (2017) (32)
- Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities (2013) (32)
- Cost‐of‐illness of patients with lymphoedema (2017) (32)
- [The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma]. (2001) (32)
- Capsaicin 8% cutaneous patch: a promising treatment for brachioradial pruritus? (2015) (32)
- Effekte kombinierter therapeutischer Maßnahmen bei Patienten mit Psoriasis und atopischer Dermatitis (1999) (32)
- Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany (2020) (31)
- Cost‐effectiveness of treating vascular leg ulcers with UrgoStart® and UrgoCell® Contact (2016) (31)
- The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings. (2017) (31)
- Biosimilars in psoriasis: What can we expect? (2014) (31)
- Development and validation of a new instrument for the assessment of patient‐defined benefit in the treatment of acne (2008) (30)
- Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis (2021) (30)
- Treatment of pyoderma gangrenosum: retrospective multicentre analysis of 121 patients (2016) (29)
- Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex (2017) (29)
- Measurement of patient‐relevant benefits in the treatment of chronic hand eczema – a novel approach (2009) (29)
- Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions – a retrospective evaluation (FACTS) (2013) (29)
- S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 1 (2019) (29)
- Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany (2017) (28)
- Double-Blind, Randomized, Intraindividual Comparison Study of the Efficacy of Prilocaine and Lidocaine in Tumescent Local Anesthesia (2010) (28)
- A systematic review on methods used to evaluate patient preferences in psoriasis treatments (2016) (28)
- Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3) (2017) (28)
- Australasian College of Dermatologists Abstracts Presented at the 52nd Annual Scientific Meeting 18–21 May 2019 Melbourne Convention and Exhibition Centre Melbourne, Victoria (2019) (28)
- Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis (2011) (28)
- Efficacy of Body Lotion Containing N-palmitoylethanolamine in Subjects with Chronic Pruritus due to Dry Skin: A Dermatocosmetic Study. (2017) (28)
- Quality of Life Measures for Dermatology: Definition, Evaluation, and Interpretation (2012) (28)
- Topische Therapie bei Psoriasis vulgaris – ein Behandlungspfad (2019) (27)
- S2k‐Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion (2016) (27)
- Clinical course, treatment modalities, and quality of life in patients with congenital melanocytic nevi – data from the German CMN registry (2017) (27)
- Secukinumab is effective in treatment of moderate‐to‐severe plaque psoriasis: real‐life effectiveness and safety from the PROSPECT study (2020) (27)
- Die Validität des Hornheider Fragebogens zur psychosozialen Unterstützung bei Tumorpatienten (2001) (27)
- Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT (2017) (27)
- Quimp (quality of life impairment): an addition to the quality of life lexicon (2018) (26)
- Prevalence and Regional Distribution of Lower Limb Amputations from 2006 to 2012 in Germany: A Population based Study. (2015) (26)
- Strategies to reduce stigma related to visible chronic skin diseases: a systematic review (2019) (26)
- Treatment goals in psoriasis routine care (2015) (25)
- Does the Dermatology Life Quality Index (DLQI) underestimate the disease‐specific burden of psoriasis patients? (2018) (25)
- Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study * (2020) (25)
- Sociodemographic profile and satisfaction with treatment of patients undergoing liposuction in tumescent local anesthesia. (1999) (25)
- Effect of secukinumab on quality of life and psoriasis‐related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52‐week study (2017) (25)
- Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse des 2. Experten‐Workshops (2011) (25)
- The impact of oral vitamin A derivatives on lipid metabolism – What recommendations can be derived for dealing with this issue in the daily dermatological practice? (2011) (25)
- Dynamic Pruritus Score: Evaluation of the Validity and Reliability of a New Instrument to Assess the Course of Pruritus. (2017) (25)
- Cost-Effectiveness of Biological Therapy in Remission Induction of Moderate to Severe Plaque Psoriasis (2010) (24)
- Cost‐of‐illness of psoriasis – results of a German cross‐sectional study (2018) (24)
- Clinical Features and Treatment Outcomes of Vitiligo from the Patients’ Perspective: Results of a National Survey in Germany (2010) (24)
- Health-Related Quality of Life and Patient-Defined Benefit of Clobetasol 0.05% in Women with Chronic Lichen Sclerosus of the Vulva (2011) (24)
- Moderne Wundtherapie – praktische Aspekte der lokalen, nicht‐interventionellen Behandlung von Patienten mit chronischen Wunden (2014) (24)
- Characterizing treatment‐related patient needs in atopic eczema: insights for personalized goal orientation (2020) (24)
- Clinical management of pruritus (2015) (24)
- Live interactive teledermatology compared to in‐person care – a systematic review (2019) (24)
- Importance of basic therapy in psoriasis (2015) (23)
- A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment (2019) (23)
- Minimal clinically important difference (MCID) for work productivity and activity impairment (WPAI) questionnaire in psoriasis patients (2018) (23)
- Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population‐based study in 161 269 employees (2019) (23)
- Effects of Mahonia aquifolium Ointment on the Expresion of Adhesion, Proliferation, and Activation Markers in the Skin of Patients with Psoriasis (1999) (23)
- Cost-Effectiveness Model of Topical Treatment of Mild to Moderate Psoriasis Vulgaris in Germany (2007) (23)
- Cost‐of‐illness of melanoma in Europe – a systematic review of the published literature (2019) (23)
- Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic (2020) (23)
- Stigma in visible skin diseases – a literature review and development of a conceptual model (2021) (23)
- Effects of psychosocial interventions on patient‐reported outcomes in patients with psoriasis: a systematic review and meta‐analysis (2018) (22)
- Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees (2017) (22)
- [Assessment of quality of life in health services research - conceptual, methodological and structural prerequisites]. (2009) (22)
- A conceptual modeling approach to health-related urban well-being (2017) (22)
- Incremental burden of cardiovascular comorbidity and psoriatic arthritis among adults with moderate‐to‐severe psoriasis in five European countries (2017) (22)
- The Wound‐QoL questionnaire on quality of life in chronic wounds is highly reliable (2017) (22)
- Patient–dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real‐world multinational survey (2018) (22)
- Therapeutischer Nutzen in der dermatologischen Behandlung (2005) (22)
- Cost-effectiveness of an 8% Capsaicin Patch in the Treatment of Brachioradial Pruritus and Notalgia Paraesthetica, Two Forms of Neuropathic Pruritus. (2017) (22)
- Psychosomatic Liaison Service in Dermatology (2001) (22)
- Phase 3 evaluation of HP802‐247 in the treatment of chronic venous leg ulcers (2016) (22)
- Validation of the disease-specific quality of life Wuerzburg Wound Score in patients with chronic leg ulcer. (2014) (21)
- Chronic leg ulcers : cost evaluation of two treatment strategies (1999) (21)
- Ustekinumab in the treatment of palmoplantar pustular psoriasis – a case series of nine patients (2016) (21)
- Participation and health care provision of statutory skin cancer screening in Germany – a secondary data analysis (2016) (21)
- Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long‐term psoriasis management (2018) (21)
- [Atopic dermatitis: S2 guidelines]. (2009) (21)
- Skin cancer prevention (2013) (21)
- [Perception of statutory skin cancer screening in the general population : Current findings on participation, knowledge and evaluation]. (2017) (21)
- Patient benefit index (PBI) in the treatment of psoriasis--results of the National Care Study "PsoHealth". (2013) (21)
- Therapeutic Benefits in Atopic Dermatitis Care from the Patients' Perspective: Results of the German National Health Care Study ‘Atopic Health' (2014) (20)
- S3‐Leitlinie zur Therapie der Psoriasis vulgaris Update – Kurzfassung Teil 1 – Systemische Therapie (2018) (20)
- Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study (2020) (20)
- Characterization of Patient-Reported Outcomes in Moderate to Severe Psoriasis (2011) (20)
- [Assessment of pruritus - current standards and implications for clinical practice : consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)]. (2012) (20)
- Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients (2009) (20)
- Atopic dermatitis shows significant cutaneous comorbidity: results from large‐scale investigations in the working population (2020) (20)
- Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare). (2018) (20)
- Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study (2020) (20)
- Influenza vaccination rate among patients with moderate to severe psoriasis (2013) (19)
- Quality of life measurement in chronic wounds and inflammatory skin diseases: Definitions, standards and instruments (2014) (19)
- Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany (2009) (19)
- [Assessment of quality of life in dermatology]. (2004) (19)
- Health economic analyses of psoriasis management: a systematic literature search (2016) (19)
- Erfassung von Pruritus – aktuelle Standards und Implikationen für die Praxis (2012) (19)
- Quality of medical care of patients with acne vulgaris in Germany – nationwide survey of pharmacy clients (2009) (18)
- Effectiveness of alitretinoin in severe chronic hand eczema: PASSION, a real-world observational study (2016) (18)
- Cost‐effectiveness of secukinumab as first biologic treatment, compared with other biologics, for moderate to severe psoriasis in Germany (2018) (18)
- Health care characteristics of basal cell carcinoma in Germany: the role of insurance status and socio‐demographic factors (2014) (18)
- Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis (2021) (18)
- Secukinumab treatment of plaque psoriasis shows early improvement in DLQI response – results of a phase II regimen‐finding trial (2016) (18)
- Allergies in Germany – prevalence and perception by the public (2013) (18)
- Routine Skin Cancer Screening in Germany: Four Years of Experience from the Dermatologists' Perspective (2013) (18)
- Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo (2018) (18)
- Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum (2016) (18)
- Assessing the Value of Supportive Skin Care: Development and Validation of an Instrument for Evaluating Patient-Relevant Benefit (2009) (18)
- Attiutdes and Prior Experience with Respect to Alternative Medicine among Dermatological Patients: The Freiburg Questionaire on Attitudes to Naturopathy (FAN) (1999) (17)
- German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 1: Treatment goals and treatment recommendations (2021) (17)
- Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis (2019) (17)
- How do regional factors influence psoriasis patient care in Germany? (2010) (17)
- Predictors of the Quality of Life in Patients with Atopic Dermatitis (2000) (17)
- Drug supply for children with psoriasis in Germany (2013) (17)
- Compression therapy – current practice of care: level of knowledge in patients with venous leg ulcers (2016) (17)
- Topical tacrolimus (protopic) for the treatment of a localized pemphigus foliaceus (2004) (17)
- Bedarf und Motivation zu psychosozialen Interventionen bei Patienten mit malignen Hauttumoren : Psychosomatik (1997) (17)
- Ökonomische Aspekte in der chirurgischen Wundbehandlung (2008) (17)
- Quality of Life in Different Stages of Chronic Venous Insufficiency and Leg Ulcer (2002) (17)
- Waiting time and practice organization in dermatology (2015) (17)
- Quality of life in patients with primary and secondary lymphedema in the community (2017) (17)
- Health Services Research in Psoriasis – The German Approach (2009) (16)
- Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results (2020) (16)
- Efficacy of MMP-inhibiting wound dressings in the treatment of hard-to-heal wounds: a systematic review. (2020) (16)
- Regional healthcare delivery and demographic change in Germany – scenarios for dermatological care in 2035 (2017) (16)
- Translating the WHA resolution in a member state: towards a German programme on ‘Destigmatization’ for individuals with visible chronic skin diseases (2019) (16)
- Psoriasis - The Life Course Approach. (2016) (16)
- Stigmatisierungserleben bei Psoriasis – qualitative Analyse aus Sicht von Betroffenen, Angehörigen und Versorgern (2019) (16)
- Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis (2020) (16)
- Efficacy and tolerability of liposomal polyvinylpyrrolidone-iodine hydrogel for the localized treatment of chronic infective, inflammatory, dermatoses: an uncontrolled pilot study (2017) (16)
- Measuring change in subjective wellbeing: Methods to quantify recall bias and recalibration response shift (2016) (16)
- Einsatz und Wirksamkeit von Systemtherapien bei Erwachsenen mit schwerer Neurodermitis: Erste Ergebnisse des deutschen Neurodermitis‐Registers TREATgermany (2017) (16)
- Education in people with venous leg ulcers based on a brochure about compression therapy: A quasi‐randomised controlled trial (2019) (16)
- Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers. (2019) (15)
- Routine skin cancer screening in Germany: First data on the impact on health care in dermatology (2010) (15)
- Plant-based ointments versus usual care in the management of chronic skin diseases: a comparative analysis on outcome and safety. (2013) (15)
- The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non‐lesional skin (2020) (15)
- Positionspapier: Diagnostik und Therapie der Xerosis cutis (2018) (15)
- Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real‐life data of prior and concomitant use of psoriasis treatments from the PROSPECT study (2018) (15)
- Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry (2017) (15)
- Cumulative life course impairment: identifying patients at risk. (2013) (15)
- Fear of cancer progression in patients with stage IA malignant melanoma (2018) (15)
- The impact of age on psoriasis health care in Germany (2017) (15)
- S2k‐Leitlinie zum Gebrauch von Präparationen zur lokalen Anwendung auf der Haut (Topika) (2018) (15)
- A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO‐BIO‐REAL) (2020) (15)
- Mo1884 Prevalence of Inflammatory Bowel Disease Among Patients With Psoriasis and Incidence of Serious Infections in This Subset: Results From the PSOLAR Registry (2016) (15)
- Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines (2019) (15)
- Perception and image of dermatology in the German general population 2002–2014 (2017) (15)
- Impact on quality of life of alitretinoin in severe chronic hand eczema: FUGETTA real‐world study (2016) (14)
- [Melanoma patients: psychosocial stress, coping with illness and social support. A systematic review]. (1998) (14)
- Gesundheitsbezogene Lebensqualität – ein zentraler patientenrelevanter Endpunkt in der Nutzenbewertung medizinischer Maßnahmen (2015) (14)
- Kompressionstherapie – Kenntnisse und Anwendungspraxis (2014) (14)
- Quality of Health Care of Rosacea in Germany from the Patient’s Perspective: Results of the National Health Care Study RosaReal 2009 (2011) (14)
- Kompressionstherapie – Versorgungspraxis: Informationsstand von Patienten mit Ulcus cruris venosum (2016) (14)
- Cumulative Life Course Impairment (CLCI): A new concept to characterize persistent patient burden in chronic wounds (2013) (14)
- S2k guidelines for the use of topical preparations on the skin (2018) (14)
- Chronic venous leg ulcers: the future of cell-based therapies (2012) (14)
- Evidence‐based (S3) guideline for the treatment of psoriasis vulgaris – Update: “Therapeutic options” and “Efalizumab” (2010) (14)
- Results from a multicenter, comparative, epidemiological cohort study in Germany (2005) (14)
- Skin surgery under local anesthesia leads to stress-induced alterations of psychological, physical, and immune functions. (1999) (14)
- Significance of chronic pruritus for intrapersonal burden and interpersonal experiences of stigmatization and sexuality in patients with psoriasis (2021) (14)
- Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention (2018) (14)
- Increase of duodenal and ileal mucosal cytotoxic lymphocytes in juvenile idiopathic arthritis. (2010) (14)
- Feasibility of Using Qualitative Interviews to Explore Patients’ Treatment Goals: Experience from Dermatology (2016) (14)
- Nutzenbewertung der ambulanten und stationären VAC-Therapie aus Patientensicht : Multicenterstudie mit patientenrelevanten Endpunkten (2006) (13)
- Die Wahrnehmung des gesetzlichen Hautkrebsscreenings in der Allgemeinbevölkerung (2017) (13)
- PsoNet – Mehr Versorgungsqualität durch regionale Psoriasis‐Netze (2008) (13)
- Skin and Psyche – Closing the Gap (1999) (13)
- Antiinflammatorische Wirkung einer Lipolotion mit Korianderöl im Ultraviolett‐Erythemtest (2008) (13)
- Systematik der Nutzenbewertung von Arzneimitteln (2004) (13)
- [Efficacy and benefit of a 5-FU/salicylic acid preparation in the therapy of common and plantar warts--systematic literature review and meta-analysis]. (2004) (13)
- Influence of human wound exudate on the bactericidal efficacy of antiseptic agents in quantitative suspension tests on the basis of European Standards (DIN EN 13727) (2020) (13)
- [Epidemiological methods for health services research]. (2009) (13)
- Patient-relevant needs and treatment goals in nail psoriasis (2016) (13)
- Regionale fachärztliche Versorgung und demographischer Wandel in Deutschland – Szenarien zur dermatologischen Versorgung im Jahr 2035 (2017) (13)
- Accepted standards on how to give a Medical Research Presentation: a systematic review of expert opinion papers (2017) (13)
- Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers. (1998) (12)
- Development and use of guideline‐derived quality indicators for community lymphoedema (2013) (12)
- [Therapeutic benefits in dermatological therapy. Evaluation of therapy from the physician's und patient's perspective in psoriasis and atopic dermatitis]. (2005) (12)
- Perception and determinants of stigmatization of people with psoriasis in the German population (2020) (12)
- Quality of Care of Patients with Chronic Lymphoedema in Germany (2013) (12)
- Correlation of psoriasis activity with socioeconomic status: cross‐sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) (2018) (12)
- Recall of health-related quality of life: how does memory affect the SF-6D in patients with psoriasis or multiple sclerosis? A prospective observational study in Germany (2019) (12)
- Trizentrische Analyse von Kofaktoren und Komorbidität des Pyoderma gangraenosum (2016) (12)
- Stress Perception, Sleep Quality and Work Engagement of German Outpatient Nurses during the COVID-19 Pandemic (2021) (12)
- Social participation of people with chronic wounds: A systematic review (2020) (12)
- Cost‐of‐illness of atopic dermatitis in Germany: data from dermatology routine care (2021) (12)
- Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for adjuvant therapy (2016) (12)
- German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 2: Treatment monitoring and specific clinical or comorbid situations (2021) (11)
- [Inpatient treatment costs of skin diseases. Diagnosis-based cost calculation in a university dermatology clinic]. (2004) (11)
- Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members (2018) (11)
- Quality‐of‐life evaluation in chronic wounds: comparative analysis of three disease‐specific questionnaires (2017) (11)
- Societies and Associations (2000) (11)
- Health‐related quality of life and patient burden in patients with split‐thickness skin graft donor site wounds (2018) (11)
- Betriebliche Gesundheitsförderung in der Pflege (2020) (11)
- Leistungsprofi le der Deutschen Universitäts‐Hautkliniken (2013) (11)
- Validation of a Comprehensive Set of Pruritus Assessment Instruments: The Chronic Pruritus Tools Questionnaire PRURITOOLS. (2019) (11)
- Mathematische Methoden in der Geothermie (2012) (11)
- Effectiveness, tolerability, and safety of electrical stimulation of wounds with an electrical stimulation device: results of a retrospective register study. (2012) (11)
- Randomized standard-of-care-controlled trial of a silica gel fibre matrix in the treatment of chronic venous leg ulcers (2014) (11)
- [New information about fumaric acid esters (Fumaderm): results of a workshop of experts]. (2011) (11)
- Investigator’s Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials (2020) (11)
- Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care (2020) (11)
- Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial * (2022) (11)
- Reduced Risk of Mortality Associated With Systemic Psoriasis Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A Nested Case-Control Analysis. (2020) (10)
- Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis (2017) (10)
- Patient-reported outcomes as diagnostic tools and clues in chronic wounds: Considerations for practice (2015) (10)
- Economic evaluation of a tertiary prevention program for occupational skin diseases in Germany (2020) (10)
- Review of health economic analyses in atopic dermatitis: how diverse is the literature? (2018) (10)
- Drug supply for psoriasis – results from a national pharmacy network (2013) (10)
- Cumulative life course impairment in chronic wounds. (2013) (10)
- Deutsche S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 1: Therapieziele und Therapieempfehlungen (2021) (10)
- IgA-lineare Dermatose im Erwachsenenalter mit klinischen Zeichen eines Stevens-Johnson-Syndroms (1999) (10)
- Prevalence of prurigo nodularis in the United States of America: A retrospective database analysis (2020) (10)
- Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study (2016) (10)
- [Effects of combined dermatological and behavioural medicine therapy in hospitalized patients with psoriasis and atopic dermatitis]. (1999) (10)
- Association of atopy and tentative diagnosis of skin cancer – results from occupational skin cancer screenings (2017) (10)
- Versorgungsqualität der Psoriasis vulgaris in Deutschland – Ergebnisse der Nationalen Versorgungsstudie PsoHealth 2007 (2008) (10)
- The ‘Wound-QoL’: A Short Questionnaire Measuring Quality of Life in Patients with Chronic Wounds (2013) (10)
- Development and psychometric evaluation of the U.S. English Wound‐QoL questionnaire to assess health‐related quality of life in people with chronic wounds (2020) (10)
- Patient benefits in the treatment of psoriasis: long‐term outcomes in German routine care 2007–2014 (2016) (9)
- Psychosocial Characterization of Patients with Atopic Dermatitis in Conventional versus Alternative-Medical Therapy (1999) (9)
- Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy (2019) (9)
- Lymphedema - the long way to diagnosis and therapy. (2013) (9)
- Deutsche S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität (2021) (9)
- Validation of a short‐form of the Freiburg Life Quality Assessment for lymphoedema (FLQA‐LS) instrument (2018) (9)
- Local anesthetic effects of Lidocaine cream: randomized controlled trial using a standardized prick pain (2012) (9)
- Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross‐sectional survey (2018) (9)
- Regulationstherapie: Behandlung mit unspezifischen Reizen in der Dermatologie aus traditioneller und moderner Sicht (1999) (9)
- [Care for skin cancer in Germany : Provision and providers]. (2016) (9)
- Psychisches Befinden und Motivation zu psychosozialen Interventionen bei Patienten mit allergischen Erkrankungen (1999) (9)
- Internet‐supported gathering of treatment data and patient benefits in psoriasis (2010) (9)
- Registerforschung in der Dermatologie (2011) (9)
- Versorgung des Hautkrebses in Deutschland (2016) (9)
- Wirksamkeit und Nutzen eines 5‐FU‐/Salicylsäure‐haltigen Präparates in der Therapie vulgärer und plantarer Warzen – systematische Literaturübersicht und Metaanalyse (2004) (9)
- [PsoNet--more health care quality through regional psoriasis networks]. (2008) (9)
- Krankheitsbewältigung und Lebensqualität bei Patienten mit Feuermalen unter Laser-Therapie (1998) (9)
- Quality of psoriasis care in Germany – results from the nationwide health care studies PsoHealth 2004‐2017 (2021) (9)
- Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction (2020) (9)
- Effects of Autologous Keratinocyte Transplantation on the Quality of Life of Patients with Severe Chronic Leg Ulcers (2001) (9)
- EFFICACY AND SAFETY OF RISANKIZUMAB: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO- AND USTEKINUMAB-CONTROLLED, PHASE 3 TRIALS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS (2018) (9)
- [Perception of stigmatization in people with psoriasis-qualitative analysis from the perspective of patients, relatives and healthcare professionals]. (2019) (9)
- Minimal Clinically Important Difference in Chronic Pruritus Appears to be Dependent on Baseline Itch Severity. (2019) (9)
- Management of chronic pruritus: from the dermatological office to the specialized itch center: a review (2017) (9)
- Willingness to pay for a cure of low-risk melanoma patients in Germany (2018) (8)
- Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional Study. (2019) (8)
- Cost‐of‐illness of melanoma in Europe – a modelling approach (2019) (8)
- Analyse der Mobilitätsbereitschaft von Patienten unter Berücksichtigung individueller Merkmale und zweier Beispielindikationen (2017) (8)
- Baseline characteristics of patients with moderate‐to‐severe psoriasis according to previous systemic treatment exposure: the PROSE study population (2020) (8)
- [Economic aspects of surgical wound therapies]. (2008) (8)
- Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population (2020) (8)
- The definition and role of quality of life in Germany’s early assessment of drug benefit: a qualitative approach (2016) (8)
- [Psoriasis arthritis. An interdisciplinary challenge]. (2011) (8)
- Biosimilars in Dermatology – theory becomes reality (2018) (8)
- Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis. (2017) (8)
- Attitudes and Experiences towards Corticoid Treatment among Parents of Children with Atopic Dermatitis (2000) (8)
- Development and validation of a short version of the Freiburg Life Quality Assessment for chronic venous disease (FLQA-VS-10) (2015) (8)
- Analysis of patients’ willingness to be mobile, taking into account individual characteristics and two exemplary indications (2017) (8)
- Efficacy of dimethyl fumarate treatment for moderate-to-severe plaque psoriasis: presentation extracts from the 29th EADV virtual congress, 29-31 October 2020 (2021) (8)
- What is psoriasis? – Perception and assessment of psoriasis among the German population (2018) (8)
- Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany (2020) (8)
- Does climate change affect the incidence of skin and allergic diseases in Germany? (2008) (8)
- Entwicklung und Validierung eines neuen Instrumentes zur Erfassung patientendefinierten Nutzens in der Therapie der Akne (2008) (8)
- Temporal analysis of determinants for respiratory emergency department visits in a large German hospital (2018) (8)
- Guideline on allergen immunotherapy in IgE-mediated allergic diseases (2022) (8)
- TYK2 inhibition and its potential in the treatment of chronic inflammatory immune diseases (2021) (8)
- Prevalence and Medications of Atopic Dermatitis in Germany: Claims Data Analysis (2021) (7)
- Selektivverträge zu chronischen Wunden – aktueller Stand in Deutschland (2015) (7)
- Evidenzbasierte Medizin – Grundlagen und Anwendung in der Phlebologie (2003) (7)
- Epidemiology of rosacea in a population‐based study of 161,269 German employees (2021) (7)
- Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse eines Experten‐Workshops (2011) (7)
- How to weight patient-relevant treatment goals for assessing treatment benefit in psoriasis: preference elicitation methods vs. rating scales (2018) (7)
- Effektivität einer Polidocanol-Harnstoff-Kombination bei trockener, juckender Haut (2007) (7)
- A phase 4, randomized, head‐to‐head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate‐to‐severe plaque psoriasis (CHANGE) (2020) (7)
- Nutritional status and quality of nutrition in chronic wound patients (2020) (7)
- The German national consensus on wound documentation and outcomes: Rationale, working programme and current status (2014) (7)
- Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate‐to‐severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo‐controlled, phase III clinical trial (BREEZE‐AD4) * (2022) (7)
- S1 Guideline: Diagnosis and therapy of vitiligo (2022) (7)
- [Health-related quality of life: a pivotal endpoint in benefit assessment of medical procedures]. (2015) (7)
- Pharmakoökonomie der Akne – Bewertung von Nutzen und Wirtschaftlichkeit (2010) (7)
- Poor Adherence to International Cancer Prevention Recommendations Among Patients With Prostate Cancer: First Results From the MARTINI-Lifestyle Cohort. (2020) (7)
- Continued treatment with secukinumab is associated with high retention or regain of response (2019) (7)
- Patient-Reported Outcome Measures in Dermatology: A Systematic Review (2021) (6)
- The Health Behaviour of German Outpatient Caregivers in Relation to Their Working Conditions: A Qualitative Study (2021) (6)
- Assessing the quality of life of people with chronic wounds by using the cross‐culturally valid and revised Wound‐QoL questionnaire (2021) (6)
- [Association of Health Insurance and Socio-economic Factors with Health Care for Malignant Melanoma]. (2015) (6)
- The value of subcutaneous vs. oral methotrexate: real‐world data from the German psoriasis registry PsoBest (2020) (6)
- [Health services research in dermatology]. (2011) (6)
- European Society for Dermatology and Psychiatry (1999) (6)
- The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians (2018) (6)
- Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL) (2020) (6)
- Use of specific immunotherapy – a survey of 15 164 employed persons in Germany (2014) (6)
- Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care (2020) (6)
- Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Question-naire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris. (2019) (6)
- Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus (2020) (6)
- Epidemiology of Vitiligo – A Dual Population-Based Approach (2021) (6)
- Differences in patient and physician assessment of a dynamic patient reported outcome tool for chronic pruritus (2016) (6)
- [Phytotherapy in chronic dermatoses and wounds: what is the evidence?]. (1999) (6)
- [Linear IgA dermatosis in an adult with clinical signs of Stevens-Johnson syndrome]. (1999) (6)
- Association of Dietary Pattern, Lifestyle and Chronotype with Metabolic Syndrome in Elderly—Lessons from the Population-Based Hamburg City Health Study (2021) (6)
- Four years of early benefit assessment of new drugs in Germany: a qualitative study on methodological requirements for quality of life data (2017) (6)
- The Health Behaviour of German Outpatient Caregivers in Relation to the COVID-19 Pandemic: A Mixed-Methods Study (2021) (6)
- Pruritus Intensity Scales across Europe: a prospective validation study (2021) (6)
- [German national consensus on wound documentation of leg ulcer : Part 2: Routine care - classification of variable characteristics]. (2017) (6)
- Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study. (2019) (6)
- Kompressionsmittel für die Entstauungstherapie (2017) (6)
- Krankheitskosten und Lebensqualität bei Patienten mit mittelschwerer bis schwerer Psoriasis vulgaris in Deutschland: Eine multizentrische Studie (2007) (6)
- Psychosoziale Krankheitsbelastungen und Lebensqualität beim Lymphödem (1999) (6)
- S2k‐Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen – Kurzfassung Teil 2 (2019) (6)
- Nebenwirkungen und Risiken der Vakuumtherapie : Eine Übersicht (2006) (6)
- S3‐Leitlinie zur Therapie der Psoriasis vulgaris Update – Kurzfassung Teil 2 – Besondere Patientengruppen und spezielle Behandlungssituationen (2018) (6)
- Versorgungssituation gefäßmedizinischer Wunden in Deutschland (2017) (6)
- Arzneimittelversorgung von Kindern mit Psoriasis in Deutschland (2012) (6)
- Gesundheitsverhalten von Hautkrebspatienten während der Melanomnachsorge (2011) (6)
- Costs Of Compression Therapy In Venous Leg Ulcers In Germany And Modelling Of The Economic Effects Of Regional Disparities In Health Care. (2015) (5)
- Passende Verordnungsmenge und Applikation von Topika (2017) (5)
- Stationäre Behandlungskosten von Hautkrankheiten (2004) (5)
- The Role of Health Literacy among Outpatient Caregivers during the COVID-19 Pandemic (2021) (5)
- Strukturen und Leistungsmerkmale der Hautkliniken in Deutschland: Aktuelle Bestandsaufnahme und Langzeitverlauf (2021) (5)
- Therapie der Psoriasis im Kindes‐ und Jugendalter – ein deutscher Experten‐Konsens (2011) (5)
- Validation of the Spanish Wound-QoL Questionnaire. (2020) (5)
- Nationaler Konsensus zu Wunddokumentation beim Ulcus cruris (2017) (5)
- Psoriasis verursacht hohe Kosten, mindert die Produktivität am Arbeitsplatz und verringert die Lebensqualität (2011) (5)
- Health economic issues in psoriasis (2008) (5)
- Performance profiles of German university dermatology departments (2013) (5)
- Kompetenzlevel in der Wundbehandlung (2019) (5)
- Gesetzliches Hautkrebsscreening in Deutschland: Wahrnehmung in der Öffentlichkeit (2012) (5)
- Rapid improvement of psoriasis in a patient with lung cancer after treatment with erlotinib (2018) (5)
- Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis (2022) (5)
- Regionale Unterschiede in der Versorgung des Basalzellkarzinoms (2016) (5)
- LEBENSQUALITAT BEI HAUTERKRANKUNGEN (1999) (5)
- Nagelpsoriasis – eine therapeutische Herausforderung in Klinik und Praxis (2013) (5)
- [Pharmacoeconomy in acne--evaluation of benefit and economics]. (2010) (5)
- Antiinflammatorische Wirksamkeit von 7 Pflanzenextrakten im Ultraviolett-Erythemtest (2013) (5)
- Adherence to Guideline-Oriented Preventive Measures in Patients with Atopic Dermatitis in Germany (2021) (5)
- Inpatient care for skin diseases in Germany: multi‐source analysis on the current and future health care needs (2021) (5)
- Erratum zu: Versorgung des Hautkrebses in Deutschland. Leistungsvolumina und -erbringer (2016) (5)
- Erfassung der Lebensqualität bei chronischen Wunden und Gefäßerkrankungen (2015) (5)
- Influence of learning disabilities on the tumour predisposition syndrome NF1--survey from adult patients' perspective. (2014) (5)
- Allergien in Deutschland – Häufigkeit und Wahrnehmung in der Bevölkerung (2013) (5)
- Epidemiologie von Hautkrankheiten in Deutschland: systematische Literaturanalyse des aktuellen Forschungsstands – Teil 1: Tumorerkrankungen der Haut (2022) (5)
- Impact of Psoriatic Disease on Quality of Life: Interim Results of a Global Survey (2022) (5)
- Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab". (2010) (5)
- [Primary prevention in the context of skin cancer screening]. (2019) (5)
- How should electronic health records be designed? A cross-sectional study in patients with psoriasis (2019) (5)
- Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study (2021) (5)
- [Improved quality of healthcare through dermatological health services research : Effects of structured programs on psoriasis and skin cancer]. (2018) (5)
- Nationaler Konsensus zur Wunddokumentation beim Ulcus cruris (2017) (5)
- [Adequate prescription and application of topicals : How to calculate the right volume for the prescription of ointment needed?] (2018) (5)
- Psychodermatology Has Grown out of Its Infancy (2004) (5)
- Gesundheitsverhalten und -förderung von ambulanten Pflegekräften (2021) (4)
- Characteristics of Patients Receiving Psychotherapeutic Interventions within a Psychosomatic Liaison Service in Dermatology (2001) (4)
- Methods of analyzing regional dermatological care as exemplified by the city of Hamburg (2015) (4)
- Generalized pustular psoriasis: overview of the status quo and results of a panel discussion (2022) (4)
- Assessing the Importance of Treatment Goals in Patients with Psoriasis: Analytic Hierarchy Process vs. Likert Scales (2018) (4)
- Epidemiology of urticaria in German children (2021) (4)
- Circulating Vitamin D and Selenium Levels and Outcome in Prostate Cancer Patients: Lessons from the MARTINI-Lifestyle Cohort. (2021) (4)
- Registerforschung in der Gefäßmedizin (2012) (4)
- How do dermatologists’ personal models inform a patient‐centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast) (2022) (4)
- Health services research in dermatology – current update and perspectives (2007) (4)
- [Compression devices for decongestion therapy : A cross-sectional observational survey of handling, pressure, and comfort]. (2018) (4)
- [Health services research in dermatology. Current status]. (2011) (4)
- Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study (2020) (4)
- Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics. (2011) (4)
- Aktualisierung„ Systemtherapie bei Neurodermitis“ zur S2k‐Leitlinie Neurodermitis (2021) (4)
- Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial (2021) (4)
- S2k-Guideline for Teledermatology. (2021) (4)
- Epidemiology of skin diseases in Germany: systematic review of the current state of research – part 2: non‐infectious skin diseases (2022) (4)
- Societies and Associations · Mitteilungen der Verbände (2001) (4)
- Etanercept in der Therapie der juvenilen Psoriasis (2012) (4)
- S3‐Leitlinie zur Therapie der Psoriasis vulgaris – Update: „Übersicht der Therapieoptionen” und „Efalizumab” (2009) (4)
- [New insights into fumaric acid esters (Fumaderm ®):results of the 2nd Expert Workshops]. (2012) (4)
- Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria (2020) (4)
- Multivariate Analysis of Noise, Socioeconomic and Sociodemographic Factors and Their Association With Depression On Borough Level in the City State of Hamburg, Germany (2017) (4)
- Associations of Noise and Socioeconomic and -Demographic Status on Cardiovascular and Respiratory Diseases on Borough Level in a Large German City State (2017) (4)
- Krankheitsspezifische Lebensqualität im Vergleich dreier operativer Therapien der V.-saphena-magna-Varikose (2014) (4)
- Stellenwert der Basistherapie bei Psoriasis (2015) (4)
- Long-Term Treatment with Dimethyl Fumarate for Plaque Psoriasis in Routine Practice: Good Overall Effectiveness and Positive Effect on Impactful Areas (2022) (4)
- Primärprävention im Rahmen des Hautkrebsscreenings (2019) (4)
- Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis (2021) (4)
- Postsurgical Treatment of Split Skin Graft Donor Sites in Dermatological Departments (2018) (4)
- Prävention von Hauttumoren (2013) (4)
- Development and validation of the Patient Benefit Index for peripheral arterial disease. (2018) (4)
- Which PASI Outcome Is Most Relevant to the Patients in Real-World Care? (2021) (4)
- Disease burden and patient needs and benefits in anogenital psoriasis: developmental specificities for person‐centred healthcare of emerging adults and adults (2019) (4)
- Towards patients’ understanding of health-related quality of life—a mixed-method study in psoriasis and multiple sclerosis (2019) (4)
- Stellungnahme der DDG und des BVDD zur EMEA‐Empfehlung über das Ruhen der Zulassung für Raptiva® (Efalizumab) (2009) (4)
- Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care (2020) (4)
- Epidemiology and Costs of Psoriatic Arthritis in Germany – A Retrospective Claims Data Analysis (2016) (4)
- Kompressionsverbände mit und ohne Unterpolsterung (2018) (4)
- Epidemiology and Costs of Psoriasis in Germany – A Retrospective Claims Data Analysis (2016) (4)
- Comprehensive Wound Center am Universitätsklinikum Hamburg-Eppendorf (2010) (4)
- Das Gesundheitsverhalten von Pflegekräften – aktueller Forschungsstand, Potenziale und mögliche Herausforderungen (2020) (4)
- [Prevalence of dermatomycoses in professional football players : A study based on data of German Bundesliga fitness check-ups (2013-2015) compared to data of the general population]. (2018) (4)
- Systemische Glukokortikosteroide bei Psoriasis – Versorgung jenseits der S3‐Leitlinie (2011) (4)
- Welchen Einfluss haben regionale Faktoren auf die Versorgung der Psoriasis in Deutschland? (2010) (4)
- Deutsches Psoriasis‐Register PsoBest: Zielsetzung, Methodik und Basisdaten (2014) (4)
- Wundnetze in Deutschland (2014) (4)
- Documentation of psoriasis in routine care – expert consensus on a German data set (2021) (4)
- Versorgung der Akne vulgaris in Deutschland – Patientenbefragung in einem bundesweiten Apothekennetzwerk (2009) (4)
- 4th Pediatric Allergy and Asthma Meeting (PAAM) (2016) (4)
- Willingness‐to‐pay and patient‐defined benefits in the treatment of hyperhidrosis: results from the first German health services research study in hyperhidrosis (2013) (4)
- Making proper judgement when choosing a treatment for actinic keratosis (2013) (4)
- Efficacy and safety of mirikizumab in psoriasis: results from a 52‐week, double‐blind, placebo‐controlled, randomized withdrawal, phase III trial (OASIS‐1) (2022) (4)
- [Etanercept in juvenile psoriasis]. (2012) (4)
- Versorgungsprozesse der Psoriasis in Deutschland — Langzeitanalyse von Sekundärdaten der gesetzlichen Krankenversicherung (2012) (4)
- Dermatologische Versorgungsforschung in Deutschland (2011) (3)
- [Unilateral cervicofacial emphysema after dental treatment. Case report]. (2007) (3)
- Incidence of atopic conditions in people with psoriasis: a population-based analysis (2021) (3)
- Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries. (2017) (3)
- Psoriasis Healthcare and Facts in Europe. For decision makers and stakeholders (2018) (3)
- Chronische Wunden schlecht versorgt? (2015) (3)
- Arzneimittelversorgung bei Psoriasis — Ergebnisse aus einem bundesweiten Apothekennetzwerk (2013) (3)
- Determining the Minimal Important Difference for the Wound-QoL Questionnaire (2021) (3)
- [A standard data set for the evaluation of venous leg ulcers in selective contracts : National consensus]. (2017) (3)
- Epidemiologie der Urtikaria bei Kindern in Deutschland (2021) (3)
- [Coping with illness and quality of life of patients with port-wine stains treated with laser therapy]. (1998) (3)
- Education in Psychodermatology: Herpes labialis and genitalis (2001) (3)
- [Psychological status and motivation for psychosocial intervention in patients with allergic disorders]. (1999) (3)
- Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison (2021) (3)
- Validation of a short form FLQA-LS quality of life instrument for lymphedema. (2018) (3)
- Biologikanebenwirkungen bei Psoriasis (2018) (3)
- [Challenges of aging skin: Care and therapy using the example of venous ulcers]. (2016) (3)
- 28200 Effects of ruxolitinib cream on work productivity and activity impairment in patients with atopic dermatitis: Pooled results from two phase 3 studies (2021) (3)
- An indirect comparison of long‐term efficacy of every‐2‐week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12 (2020) (3)
- Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variations (2022) (3)
- Workplace Health Promotion and COVID-19 Support Measures in Outpatient Care Services in Germany: A Quantitative Study (2021) (3)
- Patient needs and benefits of sublingual immunotherapy for grass pollen-induced allergic rhinitis: an observational study. (2021) (3)
- Versorgungsforschung in der Dermatologie – aktuelle Bestandsaufnahme und Perspektiven (2007) (3)
- Attitudes towards using electronic health records of patients with psoriasis and dermatologists: a cross-sectional study (2020) (3)
- Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3) (2018) (3)
- Epidemiology of skin diseases in Germany: systematic review of the current state of research – part 1: cutaneous tumor diseases (2022) (3)
- Skin Lesions, Skin Care, and Characteristics of Pruritus in Patients Undergoing Haemodialysis (2021) (3)
- Papillomatös wachsender Knoten am Unterarm mit akuter Lymphangitis (2009) (3)
- [Chronic pruritus : Care in daily practice]. (2016) (3)
- Power through standards: The Federal Conference for Outcome Measurement and Benefit Assessment of Chronic Wounds Stärke durch Standards: Bundes konferenz zur Ergebnismessung und Nutzenbewertung bei chronischen Wunden (2016) (3)
- PSS25 Validation of the Patient Benefit Index (PBI) for the Assessment of Patient-Defined Benefit in the Treatment of Psoriasis (2012) (3)
- Measuring the importance of health domains in psoriasis – discrete choice experiment versus rating scales (2018) (3)
- [German national consensus on wound documentation of leg ulcer : Part 1: Routine care - standard dataset and minimum dataset]. (2017) (3)
- Sozioökonomische Bedeutung allergischer Erkrankungen (2021) (3)
- Epidemiology and health care situation of chronic wounds in Germany Epidemiologie und Versorgungs situation chronischer Wunden in Deutschland (2016) (3)
- Impact of the COVID‐19 pandemic on the care of patients with malignant melanoma (2022) (3)
- Determinants of costs and benefits in psoriasis routine care: results from a cross‐sectional nationwide study in Germany (2020) (3)
- Benefits of a membership in a psoriasis patient organisation: a quasi-experimental longitudinal study (2018) (3)
- Biologika und Immunglobuline für die Therapie des Pyoderma gangraenosum – Analyse von 52 Patienten (2019) (3)
- [Compression bandages with and without padding : Observational controlled survey of pressure and comfort]. (2018) (3)
- Modelling first‐year cost‐of‐illness of melanoma attributable to sunbed use in Europe (2019) (3)
- Versorgungsmerkmale des Basalzellkarzinoms in Deutschland: Die Rolle von Versichertenstatus und soziodemographischen Faktoren (2014) (3)
- Klinisches Management bei Pruritus (2015) (3)
- Status quo und Perspektiven der Hautkliniken in Deutschland: Versorgungsspektren und Personalsituation (2021) (3)
- Der schöne Mensch im Alten Testament und im hellenistischen Judentum (1985) (3)
- Krebs-Screening-Programme: Methodische Grundlagen und erste Erfahrungen mit dem Hautkrebs-Screening (2011) (3)
- Stationäre Versorgung der peripheren arteriellen Verschlusskrankheit (PAVK) durch die Gefäßchirurgie (2014) (3)
- Evaluation des therapeutischen Nutzens aus Patientensicht: Der Patient Benefit Index (PBI) als Beispiel für zielorientierte Präferenz- und Outcome-Messung (2010) (2)
- [Examples of practice: clinical trials for medical devices and their application: wound care]. (2012) (2)
- Decreasing sunbed use in the German population between 2001 and 2015: survey in 155 679 working persons (2019) (2)
- [Health Atlases in Germany - An Overview]. (2018) (2)
- [Healthcare research in dermatology 2018 - power of the factual : What healthcare research is and who it serves]. (2018) (2)
- Development of a Conceptual Framework for a Patient-Reported Impact of Dermatological Diseases (PRIDD) Measure: A Qualitative Concept Elicitation Study (2022) (2)
- S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus (2022) (2)
- Topische Langzeittherapie der Psoriasis mit Vitamin‐D3‐Analoga, Kortikosteroiden und deren Kombinationen: Positionspapier zu Evidenz und praktischer Anwendung (2014) (2)
- Nutzung der spezifischen Immuntherapie ‐ eine Befragung von 15 164 Beschäftigten in Deutschland (2014) (2)
- [Side effects of biologic therapies in psoriasis]. (2018) (2)
- Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response—Data from the German HS Registry HSBest (2022) (2)
- Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study (2021) (2)
- Consensus document on electrical stimulation in treatment of chronic wounds in preparation for a national S1 Guideline (2015) (2)
- [Real world data sources for health services research on skin cancer]. (2019) (2)
- Efficacious psoriasis treatment improves patients' work productivity (2020) (2)
- Unilaterales zervikofaziales Emphysem nach Zahnbehandlung (2007) (2)
- Stationäre Versorgung von Hautkrankheiten in Deutschland: Multi‐Source‐Analyse zum aktuellen und zukünftigen Bedarf (2021) (2)
- Versorgungsforschung in der Gefäßmedizin (2011) (2)
- Intertrigo-Therapie heute. Behandlungsergebnisse mit Hamamelis virginiana (1999) (2)
- ["Schuppenflechte" or "Psoriasis"? : Wording and awareness of technical terms in the general public]. (2018) (2)
- Regional variations and prevalence of psoriasis in Germany from 2010 to 2017: a cross-sectional, spatio-epidemiological study on ambulatory claims data (2021) (2)
- [Access to statutory skin cancer screening : Organizational and regional factors in Germany]. (2019) (2)
- Documenting Patient Data in Psoriasis Clinical Practice—Patient Focus Groups Supporting Psoriasis Experts’ Decision-making (2021) (2)
- [Appropriate off-label prescription in practice]. (2013) (2)
- Cost-Effectiveness of Secukinumab as First Biologic Treatment for Psoriasis Compared with Initiating Other Biologic Therapy in Germany (2016) (2)
- Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts (2022) (2)
- [Efficacy and patient benefit of treatment of irritated skin with ointments containing dexpanthenol: health services research (observational study) on self-medication in a pharmaceutical network]. (2009) (2)
- Measuring Change in Quality of Life: Can We Distinguish Recall Bias and Scale Recalibration? (2014) (2)
- [Psycho-oncology in dermatological practice : Evaluation of need and care structures]. (2019) (2)
- Gesundheitsatlanten in Deutschland – eine Übersicht (2018) (2)
- Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany (2021) (2)
- Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments (2021) (2)
- Synopse zum Chronistischen Geschichtswerk (1987) (2)
- Praxisbeispiele zu klinischen Studien mit Medizinprodukten und deren Anwendung: Wundversorgung (2012) (2)
- Prävalenz und medikamentöse Therapie des arteriellen Hypertonus der erwerbstätigen Bevölkerung in Deutschland (2014) (2)
- Epidemiologie, Versorgungsbedarf und Versorgungsvolumina peripherer Venenkrankheiten in Deutschland: Multi-Source Analyse von Primärund Sekundärdaten Epidemiology, health care needs and care volumes of peripheral venous diseases in Germany: multi-source analysis of primary and secondary data (2018) (2)
- [Benefits and limitations of vacuum therapy in wounds]. (2007) (2)
- Interne Diagnosevalidierung von Patienten mit einer floriden chronischen Wunde - Möglichkeiten der Identifizierung auf der Basis von Routinedaten (2019) (2)
- Was ist Schuppenflechte? – Wahrnehmung und Bewertung der Psoriasis in der deutschen Bevölkerung (2018) (2)
- Clinical performance and quality of life impact of an absorbent bacteria-binding foam dressing. (2021) (2)
- Das Deutsche Wundregister (DWR) – Konzept und Sachstand (2012) (2)
- Systemische Psoriasistherapie während der Schwangerschaft (2019) (2)
- Patientennutzen und Anwendungsmerkmale der Behandlung irritierter Haut mit dexpanthenolhaltiger Salbe (2009) (2)
- Standarddatensatz für die Evaluation bei Selektivverträgen bei Ulcus cruris (2017) (2)
- Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study (2018) (2)
- Ist das Screening auf abdominelle Aortenaneurysmen in Deutschland möglich? (2012) (2)
- Vaskuläre Versorgungsforschung in Deutschland (2011) (2)
- Vascular Diagnostic and Surgical Treatments Before Lower Limb Amputations in Patients with Arterial Vascular Diseases: A Population Based Study from 2013 to 2015 in Germany. (2021) (2)
- Exploring the burden of xerosis cutis and the impact of dermatological skin care from patient's perspective (2021) (2)
- [Epidemiology of scabies in Germany: multisource analysis of primary and secondary data]. (2021) (2)
- Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaire. (2019) (2)
- [Recording of quality of life in dermatological studies. Guidelines of the Subcommission "Pharmacoeconomics and Quality of Life"]. (2001) (2)
- Beeinflusst der Klimawandel das Auftreten von Haut‐ und Allergiekrankheiten in Deutschland? (2008) (2)
- Versorgungsforschung in der Dermatologie (2010) (2)
- The psychobiology of cancer: Automatization and boredom in health and disease (1983) (2)
- Früherkennung der Komorbidität bei Psoriasis: Konsensusempfehlungen der Nationalen Konferenz zur Versorgung der Psoriasis (2015) (2)
- Development and validation of the Patient Benefit Index for the dermatocosmetic treatment of aged skin (2016) (2)
- Maintenance of Response with Certolizumab Pegol for the Treaatment of Chronic Plaque Psoriasis: Results of a 32-Week Re-Randomized Maintenance Period from an Onging Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT) (2017) (2)
- Organisationsstrukturen moderner Wundversorgung (2011) (2)
- [Wound networks in Germany: structure, functions and objectives 2014]. (2014) (2)
- Regional variations in the use of statutory skin cancer screenings in Germany: population‐based spatial multisource analysis (2020) (2)
- Mehr Versorgungsqualität durch dermatologische Versorgungsforschung (2018) (2)
- Erfassung diagnosebezogener Kosten mittels Bottom-up-Ansatz - Grundlage für erfolgreiches DRG-Management in der Hautklinik (2005) (2)
- Phytotherapie bei chronischen Dermatosen und Wunden: Was ist gesichert? (1999) (2)
- Arzneimittelsicherheit bei Psoriasis: Welche Rolle spielt Suizidalität? (2017) (2)
- Pharmakoökonomisches Modell zur Kosten‐Effektivität topischer Behandlungsformen bei leichter bis mittelschwerer Psoriasis vulgaris in Deutschland (2009) (2)
- [Regional differences in the health care of basal cell carcinoma]. (2016) (2)
- Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment (2020) (2)
- Wartezeiten und Behandlungsorganisation in der Hautarztpraxis (2015) (2)
- Memorandum Register f ü r die Versorgungsforschung * Memorandum Registry for Health Services Research (2010) (2)
- Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies (2022) (2)
- Wirksamkeit und Sicherheit von Fumarsäureestern bei Patienten mit Psoriasis und therapiepflichtigen Begleiterkrankungen – eine retrospektive Datenerhebung (FACTS) (2013) (2)
- Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis (2019) (2)
- Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people‐centred healthcare concept of the World Health Organization (2022) (2)
- Die Psoriasistherapie in der dermatologischen Praxis führt zu verbesserter Lebensqualität - Ergebnisse einer naturalistischen Multizenter-Studie (2005) (2)
- Wound dressings for leg ulcers in Germany: Distribution, regional variations and health care providers (2018) (2)
- Quality of life assessment and use of patient-reported outcomes in practice (2017) (2)
- Sunbeds: An international common concern (2019) (1)
- Inanspruchnahme der Grippeschutzimpfung bei Patienten mit mittelschwerer oder schwerer Psoriasis (2013) (1)
- Krankheitsverlauf, medizinische Versorgung und Lebensqualität von Patienten mit kongenitalen melanozytären Nävi – Auswertung des deutschsprachigen KMN‐Registers (2017) (1)
- Untersuchungen zur Effektivität von Clobetasol 0,05 % in der Therapie des Lichen sclerosus der Vulva (2008) (1)
- Patient Needs and Treatment Goals in Clinical Care of Chronic Pruritus (2016) (1)
- Epidemiology of seborrheic dermatitis (2019) (1)
- The comparative efficacy for novel treatments of moderate to severe plaque psoriasis: A network metaanalysis (2019) (1)
- Sachwortverzeichnis Band 1, 2000 (2000) (1)
- 28194 Patient-reported outcomes of ruxolitinib cream for the treatment of atopic dermatitis: Pooled results from two phase 3 studies (2021) (1)
- New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany (2020) (1)
- Epidemiologie und Therapie von erwachsenen Patienten mit atopischer Dermatitis (2021) (1)
- PRS9 Budget Impact Analysis Of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis (2011) (1)
- PSS4 COST-OF-ILLNESS IN PATIENTS WITH CHRONIC HAND ECZEMA: RESULTS FROM A MULTI-CENTRE STUDY IN GERMANY (2010) (1)
- Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis: Interim Results From A Large Prospective, Observational Study. (2015) (1)
- [Expanding papillomatous nodule on forearm with acute lymphangitis. Case of diagnosis]. (2009) (1)
- Methodological Requirements Regarding Quality of Life Measurement in the Early Assessment of Benefit In Germany. (2014) (1)
- Chronischer Pruritus (2016) (1)
- Versorgungsforschung in der Dermatologie 2018 – Kraft des Faktischen (2018) (1)
- [Internal diagnostic validation of patients with a chronic wound: possibilities of identification on the basis of routine data]. (2019) (1)
- 27368 Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the BE VIVID bimekizumab in moderate to severe plaque psoriasis phase 3 trial (2021) (1)
- Sunbed use in Europe: Time for information (2019) (1)
- Health services in older psoriasis patients before and after nursing home admission (2022) (1)
- Der Einfluss von Alitretinoin auf die Lebensqualität bei Patienten mit schwerem chronischen Handekzem: FUGETTA ‐ Beobachtungsstudie unter Praxisbedingungen (2016) (1)
- A Structured Intervention for Medical Students Significantly Improves Awareness of Stigmatisation in Visible Chronic Skin Diseases: A Randomised Controlled Trial (2021) (1)
- Clinical evaluation of UrgoStart Plus dressings in real-life conditions: results of a prospective multicentre study on 961 patients. (2021) (1)
- [Tumescent technique for local anesthesia. Use and prospectives of aa new anesthetic method]. (1999) (1)
- Das Deutsche Psoriasis-Register PsoBest: Sicherheit und Wirksamkeit der Biologika- und Systemtherapie bei Psoriasis und Psoriasis-Arthritis – 48 Monate Pharmakovigilanz (2012) (1)
- [Psoriasis therapy in pregnancy : Consultation of pregnant patients]. (2019) (1)
- Kaltplasma‐Therapie bei Pyoderma gangrenosum (2021) (1)
- Navigating the Road to Psoriasis Control in Women : Strategies to Optimise the Reproductive Journey (2018) (1)
- Increasing competence in compression therapy for venous leg ulcers through training and exercise measured by a newly developed score—Results of a randomised controlled intervention study (2021) (1)
- „Ein Ort, an dem sich alle treffen, die täglich kämpfen“ (2018) (1)
- Effectiveness of a structured short intervention against stigmatisation in chronic visible skin diseases: Results of a controlled trial in future educators (2021) (1)
- A multidimensional overview of the burden of psoriasis (2018) (1)
- Hautkrebsscreening als Regelleistung der gesetzlichen Krankenkassen: Auswirkungen auf die dermatologische Versorgung (2011) (1)
- Health Related Quality of Life-Outcome in National Care - Real World Data from the German Psoriasis-Registry “Psobest” (2013) (1)
- Disease related stress in children with Neurofibromatosis type 1 in Germany from their own and their parents´ perspective (2012) (1)
- 857 Psoriasis-related quality-of-life differs by race/ethnicity (2019) (1)
- [Sucrose octasulfate-evidence in the treatment of chronic wounds]. (2020) (1)
- Industrial Forum – Lilly Qualitiy of Life Preis, 1999 (2000) (1)
- „Schuppenflechte“ oder „Psoriasis“? (2018) (1)
- Band 1, Heft 4, Dezember 2000 (2000) (1)
- Results from a multicenter, comparative, epidemio- logical cohort study in Germany and Switzerland (2005) (1)
- [Modern wound treatment-from best practice to innovation]. (2018) (1)
- The Definition and Role of Quality of Life In Germany's Early Assessment of Drug Benefit. (2014) (1)
- [Registry research in dermatology]. (2011) (1)
- Pharmacoeconomics of Occupational Diseases (2019) (1)
- Sucrose Octasulfat – Evidenz in der Behandlung chronischer Wunden (2020) (1)
- Real-world experience with apremilast in patients with psoriasis: interim analysis of 104 patients from the APPRECIATE study (2017) (1)
- Moderne Wundbehandlung – von „best practice“ zur Innovation (2018) (1)
- Calcipotriol plus Betamethasondipropionat-Gel in der Behandlung der Kopfhautpsoriasis (2010) (1)
- Patientenseitige Ziele und Erwartungen an die Behandlung der allergischen Rhinokonjunktivitis mit Allergie-Immuntherapie (2017) (1)
- Digital Health meets Hamburg integrated medical degree program iMED: concept and introduction of the new interdisciplinary 2nd track Digital Health (2020) (1)
- Durability of Response in Patients with Chronic Plaque Psoriasis Treated with Certolizumab Pegol over 48 Weeks: Pooled Results from Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT) (2018) (1)
- PSS68 - THE MOST INFLUENTIAL DRIVERS OF PSORIASIS PATIENTS’ TREATMENT CHOICE: A DISCRETE CHOICE EXPERIMENT SURVEY IN THE US (2018) (1)
- Arbeitsgemeinschaft Dermatologische Onkologie (ADO) (2015) (1)
- PSS35 COST COMPARISON OF PATIENTS WITH CHRONIC HAND ECZEMA COVERED BY STATUTORY VS. OCCUPATIONAL HEALTH INSURANCES IN GERMANY (2010) (1)
- PSN14 QUALITY OF LIFE IN PATIENTS SUFFERING FROM PSORIASIS VULGARIS IN GERMANY—A NON-INTERVENTIONAL SURVEY (2003) (1)
- Publication (translated from original German): Effectiveness of an Acellular Synthetic Matrix as an Adjunct to Standard Care in Venous and Mixed Leg Ulcers: Comparison of Clinical Study Data and Routine Data (2015) (1)
- Einsatz von Korianderöl in der Dermatologie (2012) (1)
- Forschung an der Versorgung – 10 Jahre Competenzzentrum Versorgungsforschung in der Dermatologie (CVderm) (2015) (1)
- Validierung des Patient Benefit Index (PBI) zur Erfassung des patientenrelevanten Nutzens in der Psoriasistherapie (2012) (1)
- Lymphedema – the Long Way to Diagnosis and Therapy (2013) (1)
- Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany (2020) (1)
- Methods used for indirect comparisons of systemic treatments for psoriasis. A systematic review (2022) (1)
- Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Psoriasis Registry PsoBest (2022) (1)
- Der Problempatient in der Hautarztpraxis (2000) (1)
- Comparison of validated methods for the detection of disease-specific quality of life in patients with chronic wounds (2013) (1)
- Health Economics and Skin Disease (2016) (1)
- Wirksamkeit moderner Wundauflagen – Metaanalyse (2014) (1)
- Associations between a Subjective Living Environment and Quality of Life among People with Arterial Hypertension—Results from the Hamburg City Health Study (2022) (1)
- Effects of workplace skin cancer screenings on preventive and risk behaviour (2022) (1)
- 25665 Efficacy and safety of mirikizumab in psoriasis: 52-week results from the OASIS-1 randomized controlled trial (2021) (1)
- Effektivität einer azellulären synthetischen Matrix als Ergänzung zur Standardversorgung bei Ulcus cruris venosum und mixtum: Vergleich von klinischen Studiendaten und Routinedaten. (2014) (1)
- PSS14 Burden of Disease in Patients With Severe Chronic Hand Eczema in Germany (2011) (1)
- Biosimilars in der Dermatologie – Theorie wird Realität (2018) (1)
- Die Inbesitznahme der schönen Frau aus der unterschiedlichen Sicht der Schwachen und der Mächtigen (1983) (1)
- Supplementary Material for: Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry (2017) (1)
- Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study) (2023) (1)
- Ustekinumab in der Therapie der Pustulosis palmoplantaris – Eine Fallserie mit neun Patienten (2016) (1)
- PSN8 COST-OF-ILLNESS STUDY IN PATIENTS SUFFERING FROM CHRONIC PLAQUE PSORIASIS IN GERMANY (2003) (1)
- Challenges and lessons learned from using anchoring vignettes to explore quality of life response behavior (2020) (1)
- [Giant papillomas of the tongue and pharynx in focal dermal hypoplasia: a case report]. (2012) (1)
- Das Hautkrebsscreening als Regelleistung der gesetzlichen Krankenkassen: Erste Daten zu den Auswirkungen auf die dermatologische Versorgung (2010) (1)
- Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study (2022) (1)
- Development of a model to predict closure of chronic wounds in Germany: Claims data analysis (2021) (1)
- Zugang zum gesetzlichen Hautkrebsscreening (2019) (1)
- Nachdenken über Israel, Bibel und Theologie : Festschrift für Klaus-Dietrich Schunck zu seinem 65. Geburtstag (1994) (1)
- Real-world-Datenquellen für die Versorgungsforschung zum Hautkrebs (2018) (1)
- Lebensqualität und Behandlungsziele bei Psoriasis aus Patientensicht: Ergebnisse eines österreichweiten Querschnitt‐Survey (2018) (1)
- [Calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis. A review]. (2010) (1)
- Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies. (2021) (1)
- Unguentum lymphaticum bei Lympherkrankungen – heutiger Erkenntnisstand und Perspektiven (1999) (1)
- Risikomerkmale und Überlebensrate des malignen Melanoms in Deutschland und den Niederlanden (2016) (1)
- Off-label-Use (2013) (1)
- Methoden zur Analyse der regionalen dermatologischen Versorgung am Beispiel Hamburgs (2015) (1)
- [Wound management with enzyme alginogels : Expert consensus]. (2017) (1)
- Biosimilars bei Psoriasis: Was können wir erwarten? (2014) (1)
- [Alternative medicine therapy in dermatology: dimensions, chances and approaches to an integrative understanding]. (1999) (1)
- Deutsche Synopse zum chronistischen Geschichtswerk (1993) (1)
- Der Freiburger Fragebogen zur Lebensqualität bei Hauterkrankungen: Validierung und klinische Ergebnisse an 1865 Patienten (2000) (1)
- Prevalence and Cutaneous Comorbidity of Acne Vulgaris in the Working Population (2021) (1)
- Comparison of handling, pressure and wearing comfort of different compression devices for decongestion therapy (2018) (1)
- Naturheilkundliche Therapie in der Dermatologie: Dimensionen, Chancen und Wege zu einem integrativen Verständnis (1999) (1)
- Safety in National Care - Real World Data from the German Psoriasis-Registry “Psobest” (2013) (0)
- 10.3 Der Weg zur Diagnose (2010) (0)
- 7.6 Maligne vaskuläre Tumoren der Haut (2010) (0)
- Sachwortverzeichnis Band 2, 2001 (2001) (0)
- 1.2 Formen und Einteilungen (2010) (0)
- [Cost effectiveness of treating skin grafts with a special hydrogel formulation]. (2005) (0)
- 25.8 Erektile Dysfunktion (ED) (2010) (0)
- GESCHICHTSBUCHER / HISTORICAL BOOKS (2009) (0)
- Versorgungssituation von Erwachsenen mit allergischer Rhinokonjunktivitis in Deutschland (2013) (0)
- Dupilumab but not cyclosporine treatment shifts the microbiome towards a healthy skin flora in patients with moderate to severe atopic dermatitis. (2023) (0)
- Epidemiologie chronischer Wunden: Wie können wir valide Daten generieren? (2016) (0)
- 24.1 Anatomie des Nagels und morphologische Veränderungen (2010) (0)
- Vorsorge ist besser als Therapie (2012) (0)
- 1.3 Funktionen der Haut (2005) (0)
- 17.6 Hereditäre Epidermolysen (2010) (0)
- Beeinflussung des Fettstoffwechsels durch systemische Vitamin‐A‐Derivate — Welche Empfehlungen leiten sich daraus für die dermatologische Praxis ab? (2011) (0)
- 4.5 Systemische Therapie (2005) (0)
- 17.9 Erythrokeratodermien (2010) (0)
- 9.1 Grundlagen (2010) (0)
- Psychoonkologie in dermatologischen Praxen (2019) (0)
- Patientenpräferenzen bei der Behandlung von moderater bis schwerer Psoriasis: Eine Discrete-Choice-Experiment-Studie in Deutschland (2020) (0)
- 25.3 Hormonelle Regulation (2010) (0)
- 9.1 Allgemeines (2005) (0)
- SOZIALE, POLITISCHE UND KULTISCHE INSTITUTIONEN / SOCIAL AND POLITICALINSTITUTIONS, CULT AND WORSHIP (2009) (0)
- Psoriasis und Schwangerschaft (2020) (0)
- 23.3 Hyperpigmentierungen (2010) (0)
- Gesellschaftspolitische Kommentare: PsoNet: Mehr Qualität durch Vernetzung- PsoNet Deutschland sorgt für Austausch von Wissen und Erfahrungen in den regionalen Psoriasisnetzen. (2014) (0)
- Zwischen Routinedaten, Qualitätssicherung und Patientenorientierung. Gelebte Versorgungsforschung bei Psoriasis (2018) (0)
- Daten und Ergebnisse besser verstehen (2021) (0)
- 2.4 Dyshidrotisches Ekzem (2010) (0)
- Epidemiologie von Hautkrankheiten in Deutschland: systematische Literaturanalyse des aktuellen Forschungsstands – Teil 2: nichtinfektiöse Hauterkrankungen (2022) (0)
- Management der moderaten bis schweren Psoriasis mit Brodalumab im Versorgungsalltag - erste Real-World-Evidence (RWE) Ergebnisse aus der LIBERO-Studie (2020) (0)
- 26.3 Somatisierungsstörungen (2010) (0)
- Hochauflösende optische Kohärenztomographie zum In-vivo-Nachweis von Demodex-Milben (2013) (0)
- 21.2 Erkrankungen mit permanenter Gefäßerweiterung (2010) (0)
- Freie Vorträge (2013) (0)
- 8.5 Histiozytosen (2010) (0)
- Zentren- und Patientenberichte in PsoBest: Implementierung eines Feedbacksystems im Patientenregister zur Sicherung der Teilnahmemotivation und der Registervalidität (2011) (0)
- Hamburg Center for Health Economics : Schlussbericht : Laufzeit (Beginn und Ende) 01.02.2012-31.08.2016 (2017) (0)
- 8.3 Primär kutane B-Zell-Lymphome (CBCL) (2005) (0)
- 3.4 Technische Hilfsmittel (2005) (0)
- 10.1 Allgemeines (2005) (0)
- 10.1 Grundlagen (2010) (0)
- Das Comprehensive Wound Center: Interdisziplinäre Behandlung am Universitätsklinikum Hamburg (2016) (0)
- Verringerte Rezidivrate von Condylomata acuminata durch photodynamische Therapie in Kombination mit CO2-Laser (2013) (0)
- Postoperative quality of life, satisfaction, and skin condition after varicose vein surgery Postoperative Lebensqualität, Zufriedenheit und Hautzustand nach Varizenoperation (2016) (0)
- 1.5 Typ-IV-Allergien (2010) (0)
- Wirksamkeit hydroaktiver Wundauflagen im Vergleich zu konservativen Wundauflagen hinsichtlich eines kompletten Wundschlusses bei Ulcus cruris (2014) (0)
- Naturheilkunde in der Dermatologie (1999) (0)
- Evidence of the content validity, acceptability, and feasibility of a new Patient-Reported Impact of Dermatological Diseases measure (2023) (0)
- Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis (2023) (0)
- 16.1 Hämochromatosen (2010) (0)
- Dermatologische Erkrankungen bei 90.880 Beschäftigten – Sekundärdatenanalyse betrieblicher Hautkrebsscreenings (2010) (0)
- 3.10 Untersuchung der Haare (2005) (0)
- Bibelkunde des Alten Testaments : ein Arbeitsbuch (1987) (0)
- 14.1 Pruritische und urtikarielle Papeln und Plaques in der Schwangerschaft (2010) (0)
- Arzneimitteltherapie der Psoriasis-Arthritis (2017) (0)
- Auswirkungen der COVID‐19‐Pandemie auf die Versorgung von Patienten mit malignem Melanom (2022) (0)
- Routinemäßiges Hautkrebs-Screening in Deutschland: Bilanz nach 4 Jahren (2013) (0)
- 3.9 Mykologische Diagnostik (2010) (0)
- Epidemiology of skin diseases in Germany: systematic review of the current state of research – part 3: infectious skin diseases (2022) (0)
- 4.3 Lasertherapie in der Dermatologie (2010) (0)
- Distribution and perception of allergies in the German general population (2012) (0)
- 13.1 Sweet-Syndrom (2010) (0)
- 22.5 Hirsutismus (2010) (0)
- 10.3 Pemphigoid- Gruppe (2005) (0)
- 11.1 Grundlagen (2010) (0)
- Ernährungsverhalten von ambulant tätigen Pflegekräften: Eine qualitative Studie (2020) (0)
- 3.11 Phlebologische Diagnostik (2010) (0)
- S1‐Leitlinie: Diagnostik und Therapie der Vitiligo (2022) (0)
- Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (2022) (0)
- 17.8 Hereditäre Palmoplantarkeratosen (PPK) (2010) (0)
- 20.5 Weitere proktologische Krankheitsbilder (2010) (0)
- 11.4 Pityriasis rosea (2005) (0)
- Das Alte Testament als geistige Heimat : Festgabe für Hans Walter Wolff zum 70. Geburtstag (1982) (0)
- 17.5 Porphyrien (2010) (0)
- 24.2 Läsionen der Nagelplatte mit Matrixbeteiligung (2010) (0)
- Verteilung und Erreichbarkeit von Dermatologen in Hamburg (2014) (0)
- 19.2 Varikose-Syndrom (2010) (0)
- 20.1 Allgemeines (2010) (0)
- Therapierefraktäres Ulcus cruris leukozytoklastisch-vaskulitischer Genese im Rahmen eines hereditären Thrombophilie-Syndroms - Abheilung durch autologe Keratinozyten-Transplantation (BioSeed®-S) - (2002) (0)
- Stand AKP-Initiative Pruritusparameter (2011) (0)
- 8.2 Primär kutane T-Zell-Lymphome (CTCL) (2005) (0)
- Grundlagen und Praxis der Wohnmedizin (2021) (0)
- Gesundheitsökonomie und personenzentrierte Versorgung chronischer Wunden in Deutschland (2020) (0)
- Spitzentreffen zu zentralen Versorgungsthemen in der Dermatologie Prof. Josef Hecken (G‐BA) im Austausch mit DDG und BVDD (2022) (0)
- 8.1 Grundlagen (2010) (0)
- Prädiktoren der Inanspruchnahme von kardiovaskulären und respiratorischen Notfallaufnahmen – welchen Einfluss hat die Umwelt? (2019) (0)
- 2.2 Erworbenes Immunsystem (2005) (0)
- Generalisierte pustulöse Psoriasis: Überblick zum Status quo und Ergebnisse einer Diskussionsrunde (2022) (0)
- 22.1 Entwicklung, Aufbau und Wachstum der Haare (2010) (0)
- 2.1 Angeborenes Immunsystem (2005) (0)
- ILDS Newsletter No. 24 (2012) (0)
- DIE TUMESZENZ-LOKALANASTHESIE : ENTSTEHUNG, ANWENDUNG UND PERSPEKTIVE EINES NEUEN ANASTHESIEVERFAHRENS (1999) (0)
- 2.5 Hyperkeratotisch-rhagadiformes Hand- und Fußekzem (2010) (0)
- 5.3 Bakterielle Erkrankungen der Haut (2005) (0)
- Krankmachende Räume (2021) (0)
- Pharmakoökonomische Untersuchungen zur Wirtschaftlichkeit eines 5-FU/Salicylsäure-haltigen Präparates in der Therapie vulgärer Warzen (2005) (0)
- 17.7 Hereditäre Ichthyosen (2010) (0)
- Complete Contents Vol. 1, 2000 / Jahresinhalt Band 1, 2000 (2000) (0)
- Wohnraumassoziierte Erkrankungen (2021) (0)
- [Treatment of psoriasis with secukinumab : Practical guidance]. (2021) (0)
- Daten kritisch bewerten können (2021) (0)
- Internet-Dermatologie und multimediale Systeme: Grundlagen und Hinweise für Anwender (2001) (0)
- TYK2‐Inhibition: Potenzial bei der Behandlung chronisch‐entzündlicher Immunerkrankungen (2021) (0)
- Band 1, Heft 2, Juni 2000 (2000) (0)
- 21.4 Organische Angiopathien (2010) (0)
- Sozio-demographische Faktoren als Versorgungsmerkmale des Basalzellkarzinoms in Deutschland (2014) (0)
- ESDaP European Society for Dermatology and Psychiatry: General Information and Application Form (2003) (0)
- Prospektive versus retrospektive Messung von Veränderungen in der Lebensqualität: Können wir Verzerrungen durch Recall Bias und Response Shift unterscheiden? (2014) (0)
- 11.5 Morbus Reiter (2005) (0)
- A novel, fixed‐dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021 (2022) (0)
- Patienten zeigen hohe Bereitschaft, Telemedizin zu nutzen (2016) (0)
- Corticosteroid-Pulstherapie bei Alopecia areata: 10-Jahres-Langzeitergebnisse (2013) (0)
- 7.7 Kutane Paraneoplasien (2010) (0)
- Dokumentation der Psoriasis in der Routineversorgung – Expertenkonsens zu einem deutschen Datensatz (2021) (0)
- 21.3 Funktionelle Gefäßkrankheiten (2010) (0)
- 4.6 Ästhetische Dermatologie (2005) (0)
- Cumulative Life Course Impairment (CLCI): Konzept zur Beschreibung der kumulativen Lebensbelastungen bei Psoriasis (2011) (0)
- Experten-Beirat / Impressum (2013) (0)
- Vergleichende Studie der systemischen Entzündungsreaktionen bei Psoriasis vulgaris und allergischer Kontaktdermatitis (2013) (0)
- Behandlung der Psoriasis mit Secukinumab (2021) (0)
- Epidemiologie von Hautkrankheiten in Deutschland: Systematische Literaturanalyse des aktuellen Forschungsstands – Teil 3: infektiöse Hauterkrankungen (2022) (0)
- 19.5 Chronisch-venöse Insuffizienz (CVI) und Folgezustände (2010) (0)
- Freie Vorträge (2015) (0)
- 脂溢性皮炎的流行病学特征 (2019) (0)
- Wundbeurteilung und Wundinterpretation - eine Uebersicht (2006) (0)
- 17.10 Follikularkeratosen (2010) (0)
- Diagnostische Genauigkeit der 3D TOF MRA im Vergleich zur DSA für die Nachkontrolle von Patienten mit endoluminal behandelten intrakraniellen Aneurysmen: Einfluss von Aneurysmagröße und Lokalisation (2008) (0)
- 3.3 Befundbeschreibung (2005) (0)
- 3.2 Systemische Sklerodermie ( SS) (2005) (0)
- 25.5 Andrologische Diagnostik (2010) (0)
- 11.2 Der Weg zur Diagnose (2010) (0)
- Leistungsentwicklung und Versorgungsmerkmale des gesetzlichen Hautkrebsscreenings in den Hautarztpraxen (2011) (0)
- 4.1 Mechanische Hautschäden (2005) (0)
- ILDS Newsletter No. 12/2010 (2010) (0)
- The GERMELATOX DeCOG-trial: Attitude of German melanoma patients towards toxicity during adjuvant interferon treatment—Differences between the patient's and the physician's perspective. (2015) (0)
- Quality of life evaluation in lymphoedema (2018) (0)
- Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey. (2023) (0)
- Prevalence and burden of hyperhidrosis in the adult population (2012) (0)
- PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version (1970) (0)
- Contents Vol. 222, 2011 (2011) (0)
- Status quo and perspectives of dermatology hospitals in Germany: spectra of health care and staff situation (2021) (0)
- Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research (2022) (0)
- ILDS Newsletter No. 30 (2013) (0)
- PSS28 VENOUS LEG ULCER. COSTS-OF-ILLNESS OF IN GERMANY. A NATIONAL CROSS-SECTIONAL STUDY (2008) (0)
- Contents Vol. 222, 2011 (2011) (0)
- [Risk characteristics and survival rates of malignant melanoma in Germany and the Netherlands]. (2016) (0)
- 11.1 Psoriasis (2010) (0)
- Erratum / Book Review (2001) (0)
- Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns – a cross-sectional study (2022) (0)
- CLEP_A_304155 373..382 (2021) (0)
- PSS8 COSTS-OF-ILLNESS OF ULCUS CRURIS IN GERMANY: RESULTS OF TWO APPROACHES (2009) (0)
- [Social rights claims for malignant melanoma patients : Providing patient information in German dermatological practices]. (2019) (0)
- Contents Vol. 216, 2008 (2008) (0)
- AB0782 SECUKINUMAB PROVIDES IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PSORIATIC ARTHRITIS, REGARDLESS OF THE TIME SINCE DIAGNOSIS: POOLED RESULTS FROM THE SECUKINUMAB PHASE 3 TRIAL PROGRAM (2019) (0)
- Development and validation of a tool for the assessment of benefit from treatment of allergic rhinitis in children and adolescents (PBI-AR-K) (2022) (0)
- 8.4 Pseudolymphome (2010) (0)
- Use of topical applied Electrical Stimulation therapy (woundEL®) in wound healing – Case studies (2009) (0)
- Introduction of a Specific Dermatological Rehabilitation Programme for Patients with Chronic Pruritus: A Pilot Study. (2022) (0)
- WoundQoL: design and evaluation of a new questionnaire for the assessment of disease-specific quality of life with chronic wounds (2013) (0)
- Plaque psoriasis in patients with palmoplantar pustulosis (2019) (0)
- Subject Index Vol. 218, 2009 (2008) (0)
- Best evidence oder evidence based (2012) (0)
- Debridement of Venous Ulcers (2001) (0)
- UT2 Mapping DLQI on EQ-5D in Psoriasis – Transformation of Skin-Specific Health-Related Quality of Life Into Utilities (2012) (0)
- Linkage between patients’ characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry (2019) (0)
- Editorial (2000) (0)
- Chaper 24. Patient clientele and patient satisfaction (2007) (0)
- Indirect comparison of the short-, mid-, and long-term efficacy of treatments for moderate to severe plaque psoriasis: a systematic review and network meta-analysis (2022) (0)
- 20.3 Marisken (2010) (0)
- PSS26 Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): An Integrated Approach of Outcomes Measurement in Nail Psoriasis (2012) (0)
- Novel neuroendocrine controls of amphibian and human skin reepithelialisation through thyrotropin-releasing hormone (TRH) and bombesin and its mammalian homologues (2010) (0)
- Subject Index Vol. 1, 2000 (2000) (0)
- Pharmacoeconomics in Atopic Dermatitis (2004) (0)
- Front & Back Matter (2012) (0)
- 3.1 Lupus erythematodes (2005) (0)
- The 27-Item Multiple Sclerosis Quality of Life Questionnaire: A New Brief Measure Including Treatment Burden and Work Life. (2021) (0)
- S2k guideline: Diagnosis and treatment of chronic pruritus (2022) (0)
- Title : Cost-of-illness of psoriasis-results of a German cross-sectional study Running head : Cost-of-illness of psoriasis in Germany (2017) (0)
- 9.5 Necrobiosis lipoidica ( diabeticorum) (2005) (0)
- Prevalence and Associated Diseases of Seborrheic Skin in Adults (2021) (0)
- Safety of systemic psoriasis treatments evaluated in the Swiss Dermatology Network for Targeted Therapies (SDNTT) (2017) (0)
- Medicinal Treatment of Elderly Psoriasis Patients before and after Entering a Nursing Home (2022) (0)
- 34310 Bimekizumab early responses in patients with plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial (2022) (0)
- ILDS Newsletter No. 28 (2013) (0)
- 14159 Sustained improvements in itch, skin pain, and health-related quality of life through 5 years of treatment with ixekizumab in patients with moderate to severe plaque psoriasis (2020) (0)
- A trial to compare the biologic drug ixekizumab with two other treatments for psoraisis, fumaric acid esters and methotrexate (2020) (0)
- Contents Vol. 225, 2012 (2013) (0)
- [Healing wounds more quickly]. (2015) (0)
- 14.2 Pemphigoid gestationis (2010) (0)
- Using Analytic Hierarchy Process to Weight Patient-Relevant Outcomes in the Treatment of Psoriasis for Calculating the Patient Benefit Index (2016) (0)
- Psoriatic Arthritis is Associated with A Greater Economic and Humanistic Burden Among Patients with Psoriasis: Results from A Multinational Physician and Patient Survey (2016) (0)
- Contents Vol. 232, 2016 (2017) (0)
- Subject Index Vol. 2, 2001 (2001) (0)
- [Psoriasis and pregnancy : Clinical algorithm and monitoring of systemic therapy]. (2020) (0)
- [Statement of the DDG and the BVDD on the EMEA recommendations the use of raptiva [efalizumab]]. (2009) (0)
- 2.5 Tumorimmunologie (2005) (0)
- 33596 Secukinumab demonstrated sustained retention and safety in a real-world setting in patients with moderate to severe plaque psoriasis: Long-term results from an interim analysis of the SERENA study (2022) (0)
- Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy (2022) (0)
- Psychometric properties of the short version of the Freiburg Life Quality Assessment for chronic venous disease (FLQA-VS-10). (2021) (0)
- The Value of Indirect Comparisons of Systemic Biologics for Psoriasis: Interpretation of Efficacy Findings (2022) (0)
- Band 3, Heft 3, September 2002 (2002) (0)
- Acknowledgment to Referees for Dermatology 1998 (1998) (0)
- ILDS Newsletter No. 20 (2011) (0)
- The Value of Hybrid Teledermatology in German Prisons: Analysis of Routine Telemedical Data. (2023) (0)
- Waiting Times and Scheduling in Dermatological Practices in Germany (2013) (0)
- Postoperative quality of life, satisfaction, and skin condition after varicose vein surgery: Dependency on compression stocking use and Aloe vera additive (2016) (0)
- PSK2 PSOBEST. EFFECTIVENESS AND SAFETY OF LONG-TERM SYSTEMIC PSORIASIS-THERAPY: PATIENT REGISTRY OF HEALTH SERVICES IN GERMANY (2007) (0)
- Treatment Benefit Evaluation from the Patients’ Perspective: The Patient Benefit Index (PBI) as an Example of Goal-Oriented Preference and Outcomes Measurement (2010) (0)
- A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis. (2023) (0)
- Newsletter No. 5/2009 (2008) (0)
- Measuring Patient-relevant Treatment Benefit in Dermatology – Development and Validation of the Short Questionnaire “Patient Benefit Index 2.0” (2013) (0)
- Prevalence of Itch in German Schoolchildren: A Population-based Study (2022) (0)
- [Primary prevention of malignant melanoma: control of irresponsible behavior, "Sizzling two times a year in Mallorca" (interview by Dr. Elke Oberhofer)]. (2012) (0)
- Fear of progression in patients with low-risk malignant melanoma. (2017) (0)
- 33884 Complete skin clearance for patients with moderate to severe plaque psoriasis: The relationship between improvements in Psoriasis Area and Severity Index and health-related quality of life (2022) (0)
- SA52 Indirect Comparison of Short-, Mid-, and Long-Term Efficacy of Treatments for Moderate to Severe Plaque Psoriasis: A Systemic Review and Network Meta-Analysis (2022) (0)
- PSS33 Estimation of Meaningful Change on the Skindex-29 and Dermatology Life Quality Index in Patients With Chronic Hand Eczema (2011) (0)
- ESDaP European Society for Dermatology and Psychiatry / APD Arbeitskreis PsychosomatischeDermatologie (2003) (0)
- Prevalence and Risk Factors of Actinic Keratoses (2013) (0)
- 471 Conserved overall efficacy of systemic therapies in elderly psoriasis patients - a two-country, multi-center, prospective, non-interventional study (2018) (0)
- Considering Tomorrow in Today’s Treatment Choice of Women Living with Psoriasis (2019) (0)
- 12.2 Lichen ruber (2010) (0)
- 16310 Dimethyl fumarate as long-term treatment for moderate to severe plaque psoriasis in clinical practice: Interim data from the SKILL study (2020) (0)
- Structures and performance characteristics of dermatology hospitals in Germany. Current status and long‐term development (2021) (0)
- Secukinumab Provides Early and Sustained Improvements in Health-Related Quality of Life in Patients with Psoriatic Arthritis: Pooled Results from the Secukinumab Phase 3 Trial Program (2018) (0)
- PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis (2011) (0)
- Subject Index Vol. 216, 2008 (2008) (0)
- Measurement Properties of the patient-reported Psoriasis Symptom inventory daily diary in patients with moderate to severe Plaque Psoriasis (2015) (0)
- Measuring patient‐relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10‐item short form (2022) (0)
- [Predictors of Utilization of Cardiovascular and Respiratory Emergency Department Visits - what Impact does the Environment have?] (2019) (0)
- Patient clientele and patient satisfaction (2007) (0)
- 9.2 Formen (2010) (0)
- PSK10 QUANTITATIVE ASSESSMENT OF PATIENT-DEFINED BENEFIT IN DERMATOLOGY (2007) (0)
- Cutaneous expression of the B7 activation Ag and its ligand CD28: Relevance to immune responses generated in skin (1993) (0)
- Definition of psoriasis severity (2018) (0)
- Eczema herpeticatum recidivans (2007) (0)
- 5.2 Formen (2010) (0)
- 31069 Bimekizumab versus secukinumab in plaque psoriasis: Reduction in body surface area affected by psoriasis translates into benefits in patient-perceived itching, skin pain, and scaling and health-related quality of life in the BE RADIANT phase 3b trial (2022) (0)
- Book Reviews · Buchbesprechungen (2002) (0)
- PSS6 Cost-of-Illness of Chronic Lymphoedema Patients in Hamburg and Suburban Region (2012) (0)
- P107 Treatment benefit of the 5-grass tablet in children: assessment from the patient's point of view (2017) (0)
- Quality of life in dermatology (1998) (0)
- 33130 Effect of tildrakizumab on work/study-related productivity: Pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials (2022) (0)
- Development and validation of a disease-specific quality of life questionnaire for patients with peripheral artery disease (QOLPAD) (2022) (0)
- Acknowledgment to Referees (2016) (0)
- Complete Skin Clearance Is Not Attained By Most Patients Receiving Biologics For Moderate To Severe Plaque Psoriasis: Interim Results of An International, Prospective, Observational Study (2016) (0)
- [On the active metal ions of trypsins]. (1961) (0)
- PRS9 Allergies: Distribution and Perception in the German General Population (2012) (0)
- PMD24 Cost-Effetiveness of 3M ™ Coban 2 ™ Compression System in the Treatment of Lymphoedema (2011) (0)
- [Not Available]. (2016) (0)
- Chronic Venous Insufficiency (CVI) with Ulcus Cruris (2002) (0)
- Keratolytic Activity of a Novel Dimethicone Formulation (PB/LO-112) Compared to 10% Salicylic Acid Oil in Patients with Psoriasis Capitis (2017) (0)
- AB0743 Low rates of major adverse cardiac events, malignancies, and serious infections in patients with psoriasis and psoriatic arthritis treated with apremilast for ≥156 weeks: pooled analysis from the esteem and palace 1-3 phase 3 trials (2017) (0)
- 3.3 Dermatomyositis (2005) (0)
- Real‐world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry (2022) (0)
- JAMA Dermatology Peer Reviewers in 2015. (2016) (0)
- Feasibility of assessing utilities with a single-item standard gamble questionnaire in patients with melanoma (2021) (0)
- Psoriasis care in Germany: do patients who receive better care travel longer? (2022) (0)
- CLEP_A_323744 845..851 (2021) (0)
- Contents Vol. 229, 2014 (2014) (0)
- Impact of human wound exudate on the bactericidal efficacy of antiseptic products in quantitative suspension according to the European standard (DIN EN 13727) (2021) (0)
- Evaluation of the Psoriasis Area and Severity Index (PASI) as Patient Relevant Outcome in the Benefit Assessment of Psoriasis Therapies (2013) (0)
- 27505 Bimekizumab short-term and longer-term anxiety, depression, and suicidal ideation/behavior in patients with moderate to severe plaque psoriasis: Analysis of pooled data from eight phase 2/3 clinical trials (2021) (0)
- 33991 Predictors of response to secukinumab in patients with moderate to severe plaque psoriasis with special area involvement in real-world clinical setting: A pooled analysis of prospective observational studies PROSPECT, SERENA, and REALIA (2022) (0)
- Issue Information ‐ TOC (2016) (0)
- [Healthcare research in ophthalmology]. (2014) (0)
- DERMATOLOGY + PSYCHOSOMATICS: The First Two Years (2001) (0)
- Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies (0)
- 15.1 Lichen Vidal (2010) (0)
- 35205 Deucravacitinib improves Dermatology Life Quality Index (DLQI) in patients with moderate to severe psoriasis: Results from the phase 3 POETYK PSO-1 and PSO-2 trials (2022) (0)
- Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey. (2022) (0)
- Contents Vol. 218, 2009 (2008) (0)
- Contents Vol. 227, 2013 (2014) (0)
- Elevating the Standard of Care for Patients with Psoriasis: ‘Calls to Action’ from Epicensus, a Multistakeholder Pan-European Initiative (2022) (0)
- Meetings and Conferences (2000) (0)
- ILDS Newsletter No. 34 (2015) (0)
- Contents Vol. 228, 2014 (2014) (0)
- 8th International Congress on Dermatology and Psychiatry. Traces in Psychosomatic Dermatology. Paris, June 23–25, 1999 (1999) (0)
- ILDS Newsletter No. 21 (2011) (0)
- PASI 90 / 100 , DLQI 0 / 1 , and IL-17 Receptor / Cytokine : Does it Make a Difference and Are We Ambitious Enough ? (2018) (0)
- 25421 Systemic therapy of children with psoriasis—Need for intensified information and preparation before start (2021) (0)
- PSS58 A SCORING SYSTEM FOR QUALITY OF CARE EVALUATION. A COMMUNITY-BASED STUDY OF CHRONIC LEG ULCERS IN NORTH GERMANY (2008) (0)
- Psychology and Quality of Life of Patients Undergoing Liposuction Surgery (2006) (0)
- 15431 Indirect comparisons in psoriasis: Implications for clinical practice (2020) (0)
- Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis (2023) (0)
- P NMR INVESTIGATIONS OF BINARY SODIUM PHOSPHATE GLASSES (1999) (0)
- 3323 The GERMELATOX DeCOG-trial: The attitude of German melanoma patients towards toxicity during adjuvant interferon treatment - Differences between the patient's and the physician's perspective (2015) (0)
- Peer Reviewers 2015 (2015) (0)
- Population-Based Epidemiologic Study in Venous Diseases in Germany – Prevalence, Comorbidity, and Medical Needs in a Cohort of 19,104 Workers (2021) (0)
- Acknowledgement to Referees for Dermatology 2016 (2017) (0)
- Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in moderate to severe plaque psoriasis: 52-week efficacy by prior treatment in the phase 3 POETYK PSO-1 trial (2023) (0)
- PSS49 - EPIDEMIOLOGY AND TREATMENT PATTERNS IN ADULT PATIENTS WITH ATOPIC DERMATITIS: ANALYSIS OF LONGITUDINAL DATA FROM THE GERMAN STATUTORY HEALTH INSURANCE SYSTEM (2018) (0)
- 17.3 Xeroderma pigmentosum (XP) (2010) (0)
- Recent insights into comorbidities in atopic dermatitis (2023) (0)
- The efficacy of secukinumab with continued use in the treatment of psoriasis (2020) (0)
- 18540 Real-world evidence of secukinumab in psoriasis treatment: A meta-analysis of 43 studies (2020) (0)
- Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in moderate to severe plaque psoriasis: 52-week efficacy by prior treatment in the phase 3 POETYK PSO-1 trial (2022) (0)
- 19.4 Phlebothrombose (2010) (0)
- 16.7 Muzinosen (2010) (0)
- Healthcare Utilization and Treatment Patterns in Patients with Chronic Prurigo and Chronic Pruritus in Germany (2022) (0)
- Title : Cost-of-illness of patients with lymphedema Running Head : Cost-of-illness of lymphedema patients (2017) (0)
- Incremental Burden of Cardiovascular Comorbidity or Psoriatic Arthritis among Individuals with Moderate-to-Severe Psoriasis (2016) (0)
- Knowledge as to cholesterol reduction and use of phytosterol-enriched dietary foods in the general population: Insights from the Hamburg City Health Study. (2021) (0)
- 33950 Impact of psoriasis in special areas on patient quality-of-life outcomes and depression screening: Findings from the multinational UPLIFT survey (2022) (0)
- Weltweiter Psoriasis-Atlas. Grand Challenges in Global Skin Health (2014) (0)
- A pilot study on the efficacy of silicium gel on the thickness of hair in healthy women with thin hair (2008) (0)
- PSS31 Prevalence of Chronic Wounds in Germany — a Secondary Data Analysis (2012) (0)
- Health-related quality of life differs by race/ethnicity in North American patients with psoriasis: results from PSOLAR. (2022) (0)
- Development of Measurement Tools to Assess Cumulative Life Course Impairment (CLCI) in Patients with Chronic Skin Diseases. (2023) (0)
- Phlebological compression bandaging competence: comparing performance of nurses before and after one-off training. (2022) (0)
- Quality of life in atopic dermatitis patients (2008) (0)
- Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany. (2023) (0)
- ILDS Newsletter No. 19 (2011) (0)
- Newsletter ILDS No. 14 (2010) (0)
- Topical therapy with the betulin based triterpene extract (TE) in patients with chronic pruritus (2009) (0)
- 11.3 Pityriasis lichenoides (2010) (0)
- ILDS Newsletter No. 19 (2011) (0)
- Health economic issues (2008) (0)
- Diagnostische und therapeutische Maßnahmen (2021) (0)
- Epidemiologie der Skabies in Deutschland: Multi-Source-Analyse von Primär- und Sekundärdaten (2021) (0)
- Medizinische Grundlagen des Wohnens (2021) (0)
- Juckreiz: wirksame Hilfe durch innovative Basistherapie (2009) (0)
- PSS10 COST PER RESPONDER OF USTEKINUMAB VERSUS ETANERCEPT IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS: ANALYSIS FROM THE ACCEPT TRIAL (2010) (0)
- Versorgung und psychosoziale Situation von Patienten mit Neurofibromatose Typ 1 in Deutschland (2011) (0)
- 19.1 Allgemeines (2010) (0)
- Gesundheitsökonomische Evaluation der postoperativen Schmerztherapie in der Routineversorgung (2012) (0)
- 3.2 Effloreszenzen (2005) (0)
- Einrichtung und Durchfhrung einer lngsschnittlichen Versorgungsstudie zur Wundtherapie (2010) (0)
- Institutional structures of modern wound care (2011) (0)
- 3.6 Konfokale Reflexionsmikroskopie (2010) (0)
- Band 3, Heft 1, März 2002 (2002) (0)
- Patient-Benefit Index: Validierung eines neuen Messinstrumentes des Patientennutzens von Varizenoperation und Vergleich zur Lebensqualität (2011) (0)
- 19.3 Oberflächliche Thrombophlebitis (2010) (0)
- Epidemiologie und Versorgungsmerkmale des Pruritus bei Erwerbstätigen (2011) (0)
- Evaluation patientenrelevanter Nutzen in der Behandlung von Lymphödemen und Lipödemen: Entwicklung und Validierung eines neuen Instruments (2014) (0)
- Kosteneffektivität der Behandlung von Hauttransplantaten mit einer speziellen Hydrogel-Formulierung (2005) (0)
- DDA-Zertifikate: „Psoriasis“ (2018) (0)
- 7.2 Maligne epitheliale Tumoren der Haut (2010) (0)
- 1.4 Typ-III-Allergien (2010) (0)
- Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany. (2022) (0)
- 10.4 Differenzialdiagnostische Überlegungen (2010) (0)
- 24.3 Läsionen der Nagelplatte ohne Matrixbeteiligung (2010) (0)
- [Unguentum lymphaticum in lymphatic diseases--current knowledge and prospects]. (1999) (0)
- Fallserie von 10 Patienten mit Acne inversa: Einsatz von Ixekizumab bei sekundärem Wirkverlust von Adalimumab (2020) (0)
- Relevante Defizite in der Versorgung: Wer versorgt Menschen mit chronischen Wunden in Deutschland? (2016) (0)
- 2.6 Nummuläres Ekzem (2010) (0)
- Wirksamkeit, Verträglichkeit und Patientennutzen der ultraschallgestützten Wundreinigung gegenüber chirurgischem Débridement (2013) (0)
- 15.2 Zirkumskripte Sklerodermie (2010) (0)
- Individuelle kardiovaskuläre Risiken der Patientin in der Lebensmitte (2022) (0)
- Individuelle kardiovaskuläre Risiken der Patientin in der Lebensmitte (2021) (0)
- NutRiDerm – Ernährung, Lebensstil und klinische Parameter bei Patienten mit chronisch-entzündlichen Hauterkrankungen (2020) (0)
- 16.2 Kalzinosen (2010) (0)
- 3.5 Photodynamische Diagnostik (PDD) (2005) (0)
- Risk prediction model for serious infections in psoriasis (2019) (0)
- INHALTSVERZEICHNIS / TABLE OF CONTENTS (2009) (0)
- Newsletter No. 6/2009 (2009) (0)
- 17.11 Ehlers-Danlos-Syndrom (2010) (0)
- Konfokale Mikroskopie: Behandlung und zelluläre Immunantwort des Basalzellkarzinoms auf die photodynamische Therapie (2013) (0)
- DICHTUNG, UBERSETZUNG, LEXIKOGRAPHIE, HERMENEUTIK /POETRY, TRANSLATION, LEXICOGRAPHY, HERMENEUTICS (2009) (0)
- 23.1 Grundlagen (2010) (0)
- Wundbehandlung mit Enzym-Alginogelen (2016) (0)
- Sehr geehrte Kolleginnen und Kollegen, (2013) (0)
- 7.1 Basalzellkarzinom (2010) (0)
- Sozialrechtliche Ansprüche beim malignen Melanom (2019) (0)
- Nutzen und Verträglichkeit einer fixen Kombination von Clindamycin und Benzoylperoxid bei Akne vulgaris (2011) (0)
- 26.2 Chronische Hautkrankheiten mit psychischen Folgebelastungen (2010) (0)
- 26.1 Einleitung (2010) (0)
- Meetings and Conferences · Tagungen und Kongresse (2001) (0)
- Eigenart und Kontext von Jes 55: Geht Deuterojesaja mit Jes 55 zu Ende? (2004) (0)
- 5.6 Parasitäre Hauterkrankungen ( Epizoonosen) (2005) (0)
- Therapie der Psoriasis: Was Betroffene präferieren (2019) (0)
- The GERMELATOX DeCOG-trial: German melanoma patients and their attitude toward toxicity during adjuvant interferon treatment. (2014) (0)
- KAPITEL 3 – Praktische Therapie (2007) (0)
- 7.4 Maligne mesenchymale Tumoren der Haut (2010) (0)
- Vaskuläre Wundheilung (2020) (0)
- 4.2 Formen und Einteilungen (2010) (0)
- Verdis "Nabucco" und das Alte Testament (2021) (0)
- 5.7 Sexuell übertragbare Krankheiten (2005) (0)
- 16.4 Tätowierungen (2010) (0)
- Versorgungsforschung in der Berufsdermatologie (2016) (0)
- 12.1 Grundlagen (2001) (0)
- Wahrnehmung des gesetzlichen Hautkrebs-Screenings in der Allgemeinbevölkerung (2011) (0)
- 淋巴水肿患者生活质量评价 (2018) (0)
- Psoriasis bei Kindern. Sekundrdatenanalyse zur Hufigkeit und Komorbiditt (2010) (0)
- 3.2 Formen (2010) (0)
- Aspekte zu Naturheilverfahren in der Dermatologie (2000) (0)
- 3.7 Histologische Verfahren (2010) (0)
- Hauterkrankungen bei Berufstätigen: Analyse einer betrieblichen Screening-Kohorte von 18.725 Personen (2018) (0)
- 3.8 Allergologische Diagnostik (2010) (0)
- S2k‐Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen – Kurzfassung Teil 1 (2019) (0)
- Phase 3 Trial Demonstrating High Efficacy, Favourable Safety, and Convenience of a Novel Calcipotriene and Betamethasone Dipropionate Cream (2023) (0)
- 2.7 Seborrhoisches Ekzem (2010) (0)
- Krankheitskosten bei Patienten mit chronischem Handekzem in Deutschland (2011) (0)
- 24.4 Entzündungen der Nagelumgebung (2010) (0)
- Bullöse phototoxische Dermatitis durch Ruta graveolens L. (Garten- oder Weinraute) (1999) (0)
- 1.6 Arzneimittelreaktionen (2010) (0)
- 10.2 Formen und Einteilung (2010) (0)
- [Epidemiology and treatment of adult patients with atopic dermatitis : Analysis of longitudinal data of the statutory health insurance scheme]. (2021) (0)
- Newsletter ILDS No 15 (2010) (0)
- KAPITEL 2 – Diagnostische und therapeutische Verfahren in der Naturheilkunde (2008) (0)
- Erratum zu: Erfassung von Pruritus: aktuelle Standards und Implikationen für die Praxis (2012) (0)
- Altes Testament und Heiliges Land : gesammelte Studien zum Alten Testament und zur biblischen Landeskunde (1992) (0)
- Patient-reported Outcomes and Burden of Disease in Paediatric Patients with Psoriasis: Real-world Data from EU5 and US (2023) (0)
- Title Pages / 1. Interdisziplinäres Expertenforum Hautkrebs / Table of Contents / Teilnehmerverzeichnis (2011) (0)
- 4.2 Dermatochirurgische Therapieverfahren (2010) (0)
- Newsletter ILDS No 15 (2010) (0)
- 9.4 Melkersson-Rosenthal-Syndrom (2005) (0)
- Arbeitskreises Psychosomatische Dermatologie (APD), Sektion der DDG / European Society for Dermatology and Psychiatry (ESDaP) (2004) (0)
- 25.1 Anatomie der männlichen Reproduktionsorgane (2010) (0)
- 10.2 Pemphigus-Gruppe (2005) (0)
- 12.1 Prurigo-Gruppe (2010) (0)
- Nekrobiotische Form eines Granuloma annulare disseminatum - Indikation für den frühzeitigen Einsatz von Fumarsäureestern? (2011) (0)
- KAPITEL 9 – Informationen (2007) (0)
- 1.1 Makroskopische Struktur der Haut (2005) (0)
- Eingesetzte Verfahren zur Messung von Patientenpräferenzen in der Behandlung der Psoriasis – eine Übersicht mit Blick auf IQWiG und GBA (2014) (0)
- Pilotstudie zur Wirksamkeit von Kieselsäure-Gel auf die Haardicke bei gesunden Frauen mit dünnen Haaren (2007) (0)
- Das Deutsche Psoriasis-Register PsoBest: Sicherheit und Wirksamkeit der Biologika- und Systemtherapie bei Psoriasis und Psoriasis-Arthritis in der Versorgung – Versorgungsverlauf über 48 Monate Beobachtungszeit (2012) (0)
- 25.7 Andrologische Störungen im Alter (2010) (0)
- 9.6 Rheumaknoten (2010) (0)
- 1.2 Typ-I-Allergien (2010) (0)
- 4.2 Hautveränderungen durch Temperatur, Strahlen und chemische Einwirkungen (2005) (0)
- Entwicklung einer Methodik zur Erfassung der Lebensqualität sowie patientenseitiger Bedarfe und Nutzen in der Therapie des klinischen Bildes vulvovaginaler Atrophie (2012) (0)
- Psonet: Das das Frühwarn- und Überwachungssystem Europäischer Psoriasis-Register im ENCePP-Netzwerk (2011) (0)
- >>> Diagnose: Pemphigus herpetiformis assoziiert mit Thymom (2004) (0)
- Aktuelles aus dem Deutschen Psoriasis-Register PsoBest (2016) (0)
- Wirksamkeit hydroaktiver Wundauflagen im Vergleich zu konventionellen Wundauflagen hinsichtlich einer vollständigen Wundheilung bei Dekubitus und diabetischem Fuß (2015) (0)
- Stellenwert der Basistherapie bei Psoriasis Importance of basic therapy in psoriasis (2015) (0)
- 7.5 Maligne neuronale Tumoren der Haut (2010) (0)
- Wissen über berufsbedingte inhalative Noxen bei Beschäftigten im Gesundheitsdienst und der Wohlfahrtspflege (2021) (0)
- Niederfrequente Gleichstromtherapie in der Behandlung chronischer Wunden (2010) (0)
- 22.3 Veränderungen des Haarschaftes (2010) (0)
- 4.1 Phototherapie und Klimatherapie (2005) (0)
- Krankheitskosten des Lymphödems in der Metropolregion Hamburg (2012) (0)
- 25.4 Ursachen männlicher Fertilitätsstörungen (2010) (0)
- 5.5 Leishmaniosen (2005) (0)
- Professional Training · Fort- und Weiterbildung (2004) (0)
- 23.2 Hypopigmentierungen (2010) (0)
- 2.3 Abstoßungsreaktion (2005) (0)
- PAVK – eine der wichtigsten Herausforderungen der vaskulären Medizin (2014) (0)
- 25.6 Andrologische Therapie (2010) (0)
- Versorgungsforschung bei Psoriasis: Modell Deutschland (2015) (0)
- 1.3 Typ-II-Allergien (2010) (0)
- 17.2 Tuberöse Hirnsklerose (2010) (0)
- 17.4 Vergreisungssyndrome (2010) (0)
- 3.12 Andrologische Diagnostik (2010) (0)
- Supplementary Material for: Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT (2017) (0)
- Hydrogel beschleunigt Einheilen von Hauttransplantaten : Stationare Wundbehandlung wird verkürzt (2005) (0)
- Secukinumab-Behandlung führte zur Normalisierung von Lebensqualität und Krankheitssymptomen bei Psoriasis-Patienten mit oder ohne vorheriger systemischer Psoriasis-Therapie: Ergebnisse der PROSE-Studie (2020) (0)
- Welchen Einfluss soll die Nutzenbewertung nach AMNOG für den niedergelassenen Arzt haben (2017) (0)
- Wirksamkeit und Sicherheit von Secukinumab im realen klinischen Umfeld in Europa: Ergebnisse einer Zwischenanalyse der SERENA-Studie nach einem Jahr Autoren (2020) (0)
- Wie versorgen wir in Zukunft Psoriasis und Neurodermitis? (2022) (0)
- Nutzen der Mitgliedschaft in einer Patientenorganisation am Beispiel des Deutschen Psoriasis Bundes e.V.: vierarmige, quasi-experimentelle Längsschnittstudie (2014) (0)
- Haut und Psyche – die Lücke schließt sich (1999) (0)
- 1.2 Mikroskopische Struktur und Differenzierung der Haut (2005) (0)
- 13.2 Morbus Behçet (2010) (0)
- 3.1 Anamnese und klinische Untersuchung (2005) (0)
- KAPITEL 5 – Notfälle und Erste Hilfe (2007) (0)
- 21.1 Allgemeines (2010) (0)
- Antipruritische Wirkung des Triterpens Betulin bei der topischen Therapie der Urticaria factitia – eine Kasuistik (2010) (0)
- Häufigkeit und Behandlungsbedarf von Hauterkrankungen in Deutschland: Epidemiologische Studie an 48.665 Werktätigen in deutschen Unternehmen P10/04 (2007) (0)
- 6.1 Benigne Tumoren (2005) (0)
- 495 Gender stratifies psoriatic patients therapeutic needs - A two-country, multi-center, prospective, non-interventional study (2018) (0)
- Cost-effectiveness and Quality of Specialized and Routine Care in a German Cohort of Patients with Chronic Pruritus (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Matthias Augustin?
Matthias Augustin is affiliated with the following schools:
